≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

Endpoint Browser

ST19_INJURY_NERVES_LUMBAR_SPINAL_CORD_ABDOMEN_LOWER_BACK_PELVIS_LEVEL

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — S34
  • Cause of death: ICD-10 — S34

2 out of 7 registries used, show all original rules.

199

4. Check minimum number of events

None

199

5. Include endpoints

None

199

6. Filter based on genotype QC (FinnGen only)

193

Control definitions (FinnGen only)

Control exclude
ST19_INJURI_ABDOMEN_LOWER_BACK_LUMBAR_SPINE_PELVIS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
S3
Name in latin
Laesio nervorum abdominis, partis inferioris dorsi et/sive pelvis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 193 94 99
Unadjusted period prevalence (%) 0.04 0.03 0.05
Median age at first event (years) 49.84 53.75 46.13

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
199
Matched controls
1990
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S34.0
ICD-10 Finland
Concussion and oedema of lumbar spinal cord
+∞
62.9
57
*
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
257.7
57.3
56
*
W17
ICD-10 Finland
Other fall from one level to another
25.3
52.7
39
19
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
+∞
49.0
45
*
S34.2
ICD-10 Finland
Injury of nerve root of lumbar and sacral spine
+∞
41.1
38
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
8.5
35.8
55
86
NAJ32
NOMESCO Finland
Posterior reduction of fractrue of lumbar spine
+∞
34.4
32
*
N03AX16
ATC
[U] pregabalin
5.7
32.6
93
266
X59
ICD-10 Finland
Exposure to unspecified factor
5.7
31.4
84
226
XKD06
NOMESCO Finland
Physiologic investigation of micturition
12.9
29.1
30
27
S34.4
ICD-10 Finland
Injury of lumbosacral plexus
+∞
28.9
27
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.7
26.7
64
154
N03AX12
ATC
[U] gabapentin; oral
5.1
25.1
70
191
S34.1
ICD-10 Finland
Other injury of lumbar spinal cord
+∞
24.5
23
*
S34.8
ICD-10 Finland
Injury of other and unspecified nerves at abdomen, lower back and pelvis level
+∞
24.5
23
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
10.1
23.9
29
33
S34.6
ICD-10 Finland
Injury of peripheral nerve(s) of abdomen, lower back and pelvis
+∞
23.4
22
*
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
51.7
23.0
27
6
T91.1
ICD-10 Finland
Sequelae of fracture of spine
+∞
21.2
20
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.3
21.0
51
122
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
116.8
20.0
21
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.9
18.5
80
295
ZXE20
NOMESCO Finland
More than three and less than five hours
4.7
17.8
49
129
R33
ICD-10 Finland
Retention of urine
5.8
17.7
36
73
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
21.8
17.4
25
13
XKC03
NOMESCO Finland
Water cystometry
14.6
16.8
28
22
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.5
15.2
43
115
L28
ICPC
Limited function/disability (L)
3.8
15.2
59
199
S32.7
ICD-10 Finland
Multiple fractures of lumbar spine and pelvis
+∞
14.8
14
*
N02AX02
ATC
tramadol; systemic, rectal
3.2
14.5
113
581
G82.2
ICD-10 Finland
Paraplegia, unspecified
36.9
13.7
17
5
X58
ICD-10 Finland
Exposure to other specified factors
3.7
13.7
52
172
UKC02
NOMESCO Finland
Cystoscopy
3.8
13.3
48
153
ZXD05
NOMESCO Finland
Urgent procedure
3.1
13.2
83
374
N30.0
ICD-10 Finland
Acute cystitis
3.8
13.1
48
154
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.4
13.0
28
59
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
12.7
82
373
S34.3
ICD-10 Finland
Injury of cauda equina
+∞
12.6
12
*
N06AA09
ATC
amitriptyline; systemic
4.4
12.5
35
92
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
6.6
12.4
21
35
N02BF02
ATC
pregabalin; oral
4.9
12.2
29
67
N06AX21
ATC
duloxetine; oral
3.7
11.9
45
147
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.7
11.9
45
147
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
11.8
48
165
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
24.7
11.8
16
7
W19
ICD-10 Finland
Unspecified fall
4.1
11.7
36
102
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.8
11.7
28
65
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.6
11.6
30
74
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.6
11.0
28
68
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
5.5
10.8
22
44
SPAT1229
SPAT
Assessment of need for aid
5.1
10.8
24
52
R4110
NOMESCO Finland
Physiotherapy
2.8
10.1
73
346
M48.0
ICD-10 Finland
Spinal stenosis
3.7
9.9
35
109
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
9.8
41
142
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
10.9
9.7
18
18
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.7
9.7
24
57
J01MA02
ATC
ciprofloxacin; systemic
2.6
9.5
93
509
S32.4
ICD-10 Finland
Fracture of acetabulum
+∞
9.4
9
*
R52.2
ICD-10 Finland
Other chronic pain
5.4
9.3
19
38
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.6
9.1
33
104
R4120
NOMESCO Finland
Occupational therapy
4.4
9.1
24
60
Z50.1
ICD-10 Finland
Other physical therapy
5.1
9.0
20
43
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
5.3
9.0
19
39
AA1AD
NOMESCO Finland
CT of head and brain
2.6
8.9
69
336
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
14.9
8.8
14
10
N81
ICPC
Injury nervous system other
52.3
8.8
10
*
TQW40
NOMESCO Finland
Remowal of suture of skin
4.5
8.7
22
53
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
10.8
8.7
16
16
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
28.9
8.6
11
*
ZZH40
NOMESCO Finland
Substitute of bone
93.9
8.5
9
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.0
8.5
43
167
NEJ50
NOMESCO Finland
Operation of fracture of pelvic ring
+∞
8.4
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
8.3
32
105
N06AA10
ATC
nortriptyline; systemic
9.6
8.2
16
18
ZXD35
NOMESCO Finland
Usual procedure
9.6
8.2
16
18
N18
ICPC
Paralysis/weakness
10.7
8.2
15
15
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
10.7
8.2
15
15
T90.5
ICD-10 Finland
Sequelae of intracranial injury
23.1
8.1
11
5
S97
ICPC
Chronic ulcer skin
4.1
8.1
23
61
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
15.9
7.8
12
8
G83.4
ICD-10 Finland
Cauda equina syndrome
46.9
7.8
9
*
Z3231
NOMESCO Finland
Registered nurse
2.4
7.7
68
348
L89
ICD-10 Finland
Decubitus ulcer and pressure area
9.4
7.7
15
17
W00
ICD-10 Finland
Fall on same level involving ice and snow
3.1
7.6
35
128
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
7.5
38
147
S32.1
ICD-10 Finland
Fracture of sacrum
83.1
7.5
8
*
S22.4
ICD-10 Finland
Multiple fractures of ribs
11.5
7.4
13
12
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
7.3
33
119
S36.1
ICD-10 Finland
Injury of liver or gallbladder
+∞
7.3
7
*
N03AX09
ATC
lamotrigine; oral
4.1
7.3
21
56
TKC20
NOMESCO Finland
Catheterisation of bladder
4.1
7.3
21
56
S27.0
ICD-10 Finland
Traumatic pneumothorax
31.3
7.2
9
*
M54.4
ICD-10 Finland
Lumbago with sciatica
2.6
7.2
50
228
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
12.7
7.2
12
10
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.7
7.1
24
72
WX402
NOMESCO Finland
General anaesthesia
2.5
7.0
57
280
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
8.8
7.0
14
17
A28
ICPC
Limited function/disability NOS
2.7
6.9
42
179
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
6.3
6.8
17
29
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
7.3
6.7
15
22
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.2
6.6
28
97
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
6.6
29
103
N05BA01
ATC
diazepam; systemic, rectal
2.8
6.6
36
145
A06AD11
ATC
lactulose; oral
2.8
6.5
37
152
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
6.5
54
267
U71
ICPC
Cystitis/urinary infection other
3.7
6.5
21
61
M54.1
ICD-10 Finland
Radiculopathy
5.9
6.5
17
31
S92.0
ICD-10 Finland
Fracture of calcaneus
72.1
6.5
7
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
6.4
42
185
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
8.6
6.4
13
16
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
6.4
77
444
Z3226
NOMESCO Finland
Physiotherapist
2.5
6.4
46
212
U04
ICPC
Incontinence urine
4.1
6.4
18
47
XKD00
NOMESCO Finland
Uroflowmetry
2.8
6.4
36
147
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
6.4
36
147
WX704
NOMESCO Finland
Intubation
3.5
6.4
23
72
R15
ICD-10 Finland
Faecal incontinence
7.4
6.3
14
20
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
18.8
6.3
9
5
T91.2
ICD-10 Finland
Sequelae of other fracture of thorax and pelvis
+∞
6.3
6
*
S31.0
ICD-10 Finland
Open wound of lower back and pelvis
+∞
6.3
6
*
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
6.3
6
*
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
27.6
6.3
8
*
X80
ICD-10 Finland
Intentional self-harm by jumping from a high place
27.6
6.3
8
*
N02AA05
ATC
oxycodone; systemic
2.5
6.3
44
201
N06AX16
ATC
venlafaxine; oral
2.6
6.3
41
181
SPAT1211
SPAT
Application of soft bandage
3.3
6.2
25
84
B01AB05
ATC
enoxaparin; parenteral
2.2
6.2
69
386
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
9.0
6.1
12
14
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.9
6.1
16
29
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
7.6
6.0
13
18
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
7.6
6.0
13
18

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
pregabalin; oral
N02BF02 [955152]
1.5e+00
2.3e+00
3.1e+00
—
2.9e+00
3.0e+00
2.3e+00
cases:11.56%
controls:2.76%
cases:12.56%
controls:1.46%
cases:7.04%
controls:0.35%
—
—
cases:7.54%
controls:0.45%
cases:21.47%
controls:1.34%
cases:25.29%
controls:3.20%
23
55
176
1935
25
29
174
1961
14
7
185
1983
—
15
9
184
1976
41
26
150
1916
44
55
130
1662
Neurology
13 [38004458]
1.1e+00
2.2e+00
2.8e+00
—
3.3e+00
2.6e+00
2.0e+00
cases:17.09%
controls:6.48%
cases:15.58%
controls:2.06%
cases:6.53%
controls:0.40%
—
—
cases:12.56%
controls:0.50%
cases:27.75%
controls:2.73%
cases:36.21%
controls:7.28%
34
129
165
1861
31
41
168
1949
13
8
186
1982
—
25
10
174
1975
53
53
138
1889
63
125
111
1592
Orthopedic Surgery
20 [38004465]
6.9e-01
1.9e+00
3.3e+00
1.0e+50
2.8e+00
2.3e+00
1.5e+00
cases:21.61%
controls:12.16%
cases:25.13%
controls:4.67%
cases:19.60%
controls:0.90%
cases:19.10%
controls:0.00%
cases:10.05%
controls:0.65%
cases:34.55%
controls:4.94%
cases:43.68%
controls:14.27%
43
242
156
1748
50
93
149
1897
39
18
160
1972
38
0
161
1990
20
13
179
1972
66
96
125
1846
76
245
98
1472
Outpatient Visit
OP [9202]
4.4e-01
7.8e-01
1.4e+00
5.1e+00
1.8e+00
1.6e+00
1.5e+00
cases:71.36%
controls:61.71%
cases:58.79%
controls:39.50%
cases:27.64%
controls:8.84%
cases:36.18%
controls:0.35%
cases:33.67%
controls:7.91%
cases:75.92%
controls:38.52%
cases:90.23%
controls:67.44%
142
1228
57
762
117
786
82
1204
55
176
144
1814
72
7
127
1983
67
157
132
1828
145
748
46
1194
157
1158
17
559
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.2e+00
1.9e+00
2.5e+00
—
2.1e+00
2.0e+00
1.3e+00
cases:19.10%
controls:6.48%
cases:13.07%
controls:2.16%
cases:3.02%
controls:0.25%
—
—
cases:4.02%
controls:0.50%
cases:17.80%
controls:2.78%
cases:22.41%
controls:7.22%
38
129
161
1861
26
43
173
1947
6
5
193
1985
—
8
10
191
1975
34
54
157
1888
39
124
135
1593
General Surgery
2 [38004447]
6.8e-01
1.6e+00
3.2e+00
—
2.7e+00
1.8e+00
1.1e+00
cases:30.65%
controls:18.24%
cases:23.62%
controls:5.68%
cases:15.58%
controls:0.75%
—
—
cases:10.05%
controls:0.76%
cases:23.56%
controls:4.89%
cases:34.48%
controls:15.26%
61
363
138
1627
47
113
152
1877
31
15
168
1975
—
20
15
179
1970
45
95
146
1847
60
262
114
1455
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
2.1e+00
2.2e+00
—
1.0e+50
—
3.4e+00
2.6e+00
cases:4.02%
controls:0.50%
cases:3.02%
controls:0.35%
—
—
cases:5.03%
controls:0.00%
—
—
cases:8.38%
controls:0.31%
cases:9.20%
controls:0.76%
8
10
191
1980
6
7
193
1983
—
10
0
189
1990
—
16
6
175
1936
16
13
158
1704
Upper gastrointestinal surgery
106 [44777669]
6.4e-01
1.2e+00
2.9e+00
1.0e+50
3.1e+00
1.6e+00
1.3e+00
cases:13.07%
controls:7.34%
cases:8.54%
controls:2.76%
cases:5.03%
controls:0.30%
cases:3.02%
controls:0.00%
cases:5.53%
controls:0.25%
cases:10.47%
controls:2.32%
cases:25.29%
controls:8.10%
26
146
173
1844
17
55
182
1935
10
6
189
1984
6
0
193
1990
11
5
188
1980
20
45
171
1897
44
139
130
1578
Emergency Room Visit
ER [9203]
5.8e-01
1.7e+00
2.6e+00
—
2.5e+00
1.6e+00
1.1e+00
cases:43.22%
controls:29.95%
cases:34.17%
controls:8.69%
cases:17.09%
controls:1.51%
—
—
cases:12.06%
controls:1.16%
cases:32.46%
controls:9.22%
cases:54.60%
controls:28.25%
86
596
113
1394
68
173
131
1817
34
30
165
1960
—
24
23
175
1962
62
179
129
1763
95
485
79
1232
Outpatient Hospital
22 [8756]
5.8e-01
1.7e+00
2.9e+00
—
1.9e+00
1.5e+00
1.2e+00
cases:32.66%
controls:21.41%
cases:27.64%
controls:6.23%
cases:12.06%
controls:0.75%
—
—
cases:5.53%
controls:0.91%
cases:21.47%
controls:5.61%
cases:41.38%
controls:18.05%
65
426
134
1564
55
124
144
1866
24
15
175
1975
—
11
18
188
1967
41
109
150
1833
72
310
102
1407
General Practice
1 [38004446]
9.2e-01
1.4e+00
2.0e+00
—
2.5e+00
1.6e+00
1.2e+00
cases:21.61%
controls:9.90%
cases:14.07%
controls:3.77%
cases:5.03%
controls:0.70%
—
—
cases:7.54%
controls:0.65%
cases:20.42%
controls:4.94%
cases:30.46%
controls:11.18%
43
197
156
1793
28
75
171
1915
10
14
189
1976
—
15
13
184
1972
39
96
152
1846
53
192
121
1525
Physical Medicine And Rehabilitation
25 [38004468]
7.4e-01
2.0e+00
2.6e+00
1.0e+50
—
2.9e+00
2.1e+00
cases:10.55%
controls:5.33%
cases:11.56%
controls:1.71%
cases:5.03%
controls:0.40%
cases:14.57%
controls:0.00%
—
—
cases:24.08%
controls:1.65%
cases:29.31%
controls:5.07%
21
106
178
1884
23
34
176
1956
10
8
189
1982
29
0
170
1990
—
46
32
145
1910
51
87
123
1630
Psychiatry
26 [38004469]
1.1e+00
1.8e+00
1.9e+00
—
2.1e+00
1.5e+00
1.1e+00
cases:14.07%
controls:5.03%
cases:12.06%
controls:2.16%
cases:5.53%
controls:0.90%
—
—
cases:6.53%
controls:0.86%
cases:9.95%
controls:2.32%
cases:13.79%
controls:5.18%
28
100
171
1890
24
43
175
1947
11
18
188
1972
—
13
17
186
1968
19
45
172
1897
24
89
150
1628
Inpatient Hospital
21 [8717]
7.1e-01
1.9e+00
2.3e+00
—
2.1e+00
1.5e+00
9.3e-01
cases:45.23%
controls:28.94%
cases:38.19%
controls:8.79%
cases:13.07%
controls:1.56%
—
—
cases:10.55%
controls:1.41%
cases:31.41%
controls:9.17%
cases:44.25%
controls:23.82%
90
576
109
1414
76
175
123
1815
26
31
173
1959
—
21
28
178
1957
60
178
131
1764
77
409
97
1308
gabapentin; oral
N02BF01 [955005]
1.5e+00
1.4e+00
—
—
3.0e+00
2.5e+00
2.1e+00
cases:6.53%
controls:1.56%
cases:4.02%
controls:1.06%
—
—
—
—
cases:5.03%
controls:0.25%
cases:14.14%
controls:1.34%
cases:20.69%
controls:3.15%
13
31
186
1959
8
21
191
1969
—
—
10
5
189
1980
27
26
164
1916
36
54
138
1663
Office Visit
OMOP4822458 [581477]
7.8e-01
1.7e+00
3.0e+00
1.0e+50
—
2.4e+00
1.1e+00
cases:15.08%
controls:7.54%
cases:11.06%
controls:2.21%
cases:5.53%
controls:0.30%
cases:3.02%
controls:0.00%
—
—
cases:14.66%
controls:1.54%
cases:15.52%
controls:5.59%
30
150
169
1840
22
44
177
1946
11
6
188
1984
6
0
193
1990
—
28
30
163
1912
27
96
147
1621
oxycodone; oral, parenteral
N02AA05 [21604260]
1.9e+00
2.9e+00
—
—
—
1.9e+00
2.0e+00
cases:4.52%
controls:0.70%
cases:6.03%
controls:0.35%
—
—
—
—
—
—
cases:4.71%
controls:0.72%
cases:9.77%
controls:1.40%
9
14
190
1976
12
7
187
1983
—
—
—
9
14
182
1928
17
24
157
1693
Neurosurgery
14 [38004459]
1.5e+00
2.2e+00
—
1.0e+50
—
2.8e+00
1.9e+00
cases:8.54%
controls:1.96%
cases:5.53%
controls:0.65%
—
—
cases:2.51%
controls:0.00%
—
—
cases:8.90%
controls:0.57%
cases:12.64%
controls:2.15%
17
39
182
1951
11
13
188
1977
—
5
0
194
1990
—
17
11
174
1931
22
37
152
1680
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
1.2e-01
1.0e+00
2.8e+00
—
2.5e+00
1.0e+00
9.5e-01
cases:8.54%
controls:7.64%
cases:8.04%
controls:3.12%
cases:6.53%
controls:0.40%
—
—
cases:4.02%
controls:0.35%
cases:8.38%
controls:3.24%
cases:22.99%
controls:10.31%
17
152
182
1838
16
62
183
1928
13
8
186
1982
—
8
7
191
1978
16
63
175
1879
40
177
134
1540
Emergency Medicine
93 [38004510]
4.6e-01
1.2e+00
2.7e+00
1.0e+50
2.1e+00
9.2e-01
8.8e-01
cases:14.07%
controls:9.35%
cases:14.07%
controls:4.57%
cases:9.05%
controls:0.65%
cases:7.54%
controls:0.00%
cases:6.03%
controls:0.76%
cases:11.52%
controls:4.94%
cases:28.16%
controls:13.98%
28
186
171
1804
28
91
171
1899
18
13
181
1977
15
0
184
1990
12
15
187
1970
22
96
169
1846
49
240
125
1477
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
5.2e-01
1.4e+00
3.5e+00
1.0e+50
—
1.6e+00
1.0e+00
cases:9.05%
controls:5.58%
cases:8.54%
controls:2.36%
cases:8.04%
controls:0.25%
cases:2.51%
controls:0.00%
—
—
cases:8.38%
controls:1.75%
cases:17.24%
controls:7.05%
18
111
181
1879
17
47
182
1943
16
5
183
1985
5
0
194
1990
—
16
34
175
1908
30
121
144
1596
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.8e+00
1.9e+00
—
—
—
1.9e+00
1.9e+00
cases:5.53%
controls:0.95%
cases:4.02%
controls:0.60%
—
—
—
—
—
—
cases:5.24%
controls:0.82%
cases:9.77%
controls:1.57%
11
19
188
1971
8
12
191
1978
—
—
—
10
16
181
1926
17
27
157
1690
nortriptyline; oral, parenteral
N06AA10 [21604697]
2.6e+00
—
—
—
—
2.7e+00
1.9e+00
cases:5.03%
controls:0.40%
—
—
—
—
—
—
—
—
cases:5.76%
controls:0.41%
cases:5.75%
controls:0.87%
10
8
189
1982
—
—
—
—
11
8
180
1934
10
15
164
1702
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.7e-01
6.7e-01
2.4e+00
—
2.3e+00
1.2e+00
7.6e-01
cases:13.07%
controls:9.45%
cases:9.55%
controls:5.13%
cases:7.54%
controls:0.70%
—
—
cases:7.04%
controls:0.76%
cases:13.09%
controls:4.17%
cases:25.29%
controls:13.63%
26
188
173
1802
19
102
180
1888
15
14
184
1976
—
14
15
185
1970
25
81
166
1861
44
234
130
1483
General anesthesia, balanced
WX408 [2001310808]
9.4e-01
1.9e+00
1.0e+50
1.0e+50
—
2.9e+00
1.9e+00
cases:6.53%
controls:2.66%
cases:5.03%
controls:0.75%
cases:3.02%
controls:0.00%
cases:3.52%
controls:0.00%
—
—
cases:5.24%
controls:0.31%
cases:9.77%
controls:1.63%
13
53
186
1937
10
15
189
1975
6
0
193
1990
7
0
192
1990
—
10
6
181
1936
17
28
157
1689
Functional capacity evaluation
443351003 [40481051]
8.1e-01
2.3e+00
—
—
—
2.7e+00
1.6e+00
cases:3.02%
controls:1.36%
cases:4.02%
controls:0.40%
—
—
—
—
—
—
cases:5.24%
controls:0.36%
cases:8.05%
controls:1.69%
6
27
193
1963
8
8
191
1982
—
—
—
10
7
181
1935
14
29
160
1688
Physiotherapy
R4110 [2001310233]
1.1e+00
1.6e+00
—
1.0e+50
1.0e+50
2.3e+00
1.6e+00
cases:8.04%
controls:2.81%
cases:6.53%
controls:1.36%
—
—
cases:3.52%
controls:0.00%
cases:4.02%
controls:0.00%
cases:10.47%
controls:1.13%
cases:13.79%
controls:3.26%
16
56
183
1934
13
27
186
1963
—
7
0
192
1990
8
0
191
1985
20
22
171
1920
24
56
150
1661
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-3.8e-02
1.7e-01
1.6e+00
2.9e+00
2.0e+00
4.2e-01
2.9e-01
cases:17.59%
controls:18.14%
cases:15.58%
controls:13.42%
cases:13.07%
controls:2.96%
cases:4.52%
controls:0.25%
cases:16.08%
controls:2.42%
cases:18.85%
controls:13.23%
cases:29.89%
controls:24.11%
35
361
164
1629
31
267
168
1723
26
59
173
1931
9
5
190
1985
32
48
167
1937
36
257
155
1685
52
414
122
1303
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
3.2e-01
1.2e+00
2.6e+00
—
2.8e+00
4.4e-01
7.3e-01
cases:8.54%
controls:6.33%
cases:8.54%
controls:2.86%
cases:4.52%
controls:0.35%
—
—
cases:4.02%
controls:0.25%
cases:4.19%
controls:2.73%
cases:16.09%
controls:8.44%
17
126
182
1864
17
57
182
1933
9
7
190
1983
—
8
5
191
1980
8
53
183
1889
28
145
146
1572
Exposure to unspecified factor
X59 [45756412]
1.1e+00
2.1e+00
1.0e+50
1.0e+50
—
2.9e+00
1.5e+00
cases:5.53%
controls:1.91%
cases:5.53%
controls:0.70%
cases:4.02%
controls:0.00%
cases:8.54%
controls:0.00%
—
—
cases:10.47%
controls:0.67%
cases:10.34%
controls:2.56%
11
38
188
1952
11
14
188
1976
8
0
191
1990
17
0
182
1990
—
20
13
171
1929
18
44
156
1673
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-2.1e-02
1.8e-01
1.5e+00
3.1e+00
1.7e+00
2.3e-01
2.1e-01
cases:26.13%
controls:26.53%
cases:24.62%
controls:21.41%
cases:16.58%
controls:4.22%
cases:6.53%
controls:0.30%
cases:19.10%
controls:4.08%
cases:25.65%
controls:21.47%
cases:43.68%
controls:38.50%
52
528
147
1462
49
426
150
1564
33
84
166
1906
13
6
186
1984
38
81
161
1904
49
417
142
1525
76
661
98
1056
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-2.1e-02
2.1e-01
1.5e+00
3.1e+00
1.7e+00
2.4e-01
2.1e-01
cases:26.13%
controls:26.53%
cases:25.13%
controls:21.41%
cases:16.58%
controls:4.22%
cases:6.53%
controls:0.30%
cases:19.10%
controls:4.08%
cases:25.65%
controls:21.42%
cases:43.68%
controls:38.50%
52
528
147
1462
50
426
149
1564
33
84
166
1906
13
6
186
1984
38
81
161
1904
49
416
142
1526
76
661
98
1056
MCH [Entitic mass]
28539-5 [3035941]
-1.6e-02
1.8e-01
1.5e+00
3.1e+00
1.7e+00
2.4e-01
2.2e-01
cases:26.13%
controls:26.43%
cases:24.62%
controls:21.36%
cases:16.08%
controls:4.22%
cases:6.53%
controls:0.30%
cases:19.10%
controls:4.08%
cases:25.65%
controls:21.37%
cases:43.68%
controls:38.44%
52
526
147
1464
49
425
150
1565
32
84
167
1906
13
6
186
1984
38
81
161
1904
49
415
142
1527
76
660
98
1057
Platelets [#/volume] in Blood
26515-7 [3007461]
-7.8e-03
1.8e-01
1.5e+00
3.1e+00
1.7e+00
2.4e-01
2.2e-01
cases:26.13%
controls:26.28%
cases:24.62%
controls:21.36%
cases:16.08%
controls:4.22%
cases:6.53%
controls:0.30%
cases:19.10%
controls:4.08%
cases:25.65%
controls:21.37%
cases:43.68%
controls:38.44%
52
523
147
1467
49
425
150
1565
32
84
167
1906
13
6
186
1984
38
81
161
1904
49
415
142
1527
76
660
98
1057
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-1.8e-02
1.8e-01
1.5e+00
3.1e+00
1.7e+00
2.4e-01
2.2e-01
cases:26.13%
controls:26.48%
cases:24.62%
controls:21.36%
cases:16.08%
controls:4.22%
cases:6.53%
controls:0.30%
cases:19.10%
controls:4.08%
cases:25.65%
controls:21.42%
cases:43.68%
controls:38.44%
52
527
147
1463
49
425
150
1565
32
84
167
1906
13
6
186
1984
38
81
161
1904
49
416
142
1526
76
660
98
1057
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-1.8e-02
1.8e-01
1.5e+00
3.1e+00
1.7e+00
2.4e-01
2.2e-01
cases:26.13%
controls:26.48%
cases:24.62%
controls:21.36%
cases:16.08%
controls:4.22%
cases:6.53%
controls:0.30%
cases:19.10%
controls:4.08%
cases:25.65%
controls:21.37%
cases:43.68%
controls:38.44%
52
527
147
1463
49
425
150
1565
32
84
167
1906
13
6
186
1984
38
81
161
1904
49
415
142
1527
76
660
98
1057
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-1.8e-02
1.8e-01
1.5e+00
3.1e+00
1.7e+00
2.4e-01
2.2e-01
cases:26.13%
controls:26.48%
cases:24.62%
controls:21.36%
cases:16.08%
controls:4.22%
cases:6.53%
controls:0.30%
cases:19.10%
controls:4.08%
cases:25.65%
controls:21.37%
cases:43.68%
controls:38.38%
52
527
147
1463
49
425
150
1565
32
84
167
1906
13
6
186
1984
38
81
161
1904
49
415
142
1527
76
659
98
1058
Urology
34 [38004474]
6.0e-02
1.4e+00
—
—
—
2.7e+00
2.1e+00
cases:4.52%
controls:4.27%
cases:6.53%
controls:1.71%
—
—
—
—
—
—
cases:21.99%
controls:1.80%
cases:33.33%
controls:5.82%
9
85
190
1905
13
34
186
1956
—
—
—
42
35
149
1907
58
100
116
1617
Limited function/disability (L)
L28 [2002000647]
1.1e+00
2.1e+00
—
—
—
2.4e+00
1.7e+00
cases:3.52%
controls:1.26%
cases:3.52%
controls:0.45%
—
—
—
—
—
—
cases:8.90%
controls:0.88%
cases:10.34%
controls:2.10%
7
25
192
1965
7
9
192
1981
—
—
—
17
17
174
1925
18
36
156
1681
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.7e-01
5.1e-01
2.0e+00
—
2.3e+00
1.1e+00
7.8e-01
cases:14.07%
controls:10.20%
cases:9.55%
controls:5.98%
cases:5.03%
controls:0.70%
—
—
cases:6.03%
controls:0.65%
cases:13.61%
controls:5.10%
cases:26.44%
controls:14.15%
28
203
171
1787
19
119
180
1871
10
14
189
1976
—
12
13
187
1972
26
99
165
1843
46
243
128
1474
INR in Blood by Coagulation assay
34714-6 [3032080]
3.9e-01
1.2e+00
2.4e+00
—
1.6e+00
1.4e+00
1.0e+00
cases:8.04%
controls:5.58%
cases:8.04%
controls:2.56%
cases:7.04%
controls:0.70%
—
—
cases:3.52%
controls:0.71%
cases:9.95%
controls:2.73%
cases:18.39%
controls:7.51%
16
111
183
1879
16
51
183
1939
14
14
185
1976
—
7
14
192
1971
19
53
172
1889
32
129
142
1588
zolpidem; oral
N05CF02 [21604655]
1.4e+00
1.7e+00
—
—
—
1.4e+00
1.4e+00
cases:8.04%
controls:2.11%
cases:6.53%
controls:1.21%
—
—
—
—
—
—
cases:5.24%
controls:1.29%
cases:9.20%
controls:2.50%
16
42
183
1948
13
24
186
1966
—
—
—
10
25
181
1917
16
43
158
1674
Emergency Room and Inpatient Visit
ERIP [262]
6.3e-01
1.6e+00
3.2e+00
1.0e+50
—
1.1e+00
1.1e+00
cases:5.53%
controls:3.02%
cases:5.53%
controls:1.21%
cases:6.03%
controls:0.25%
cases:4.02%
controls:0.00%
—
—
cases:5.24%
controls:1.75%
cases:14.94%
controls:5.71%
11
60
188
1930
11
24
188
1966
12
5
187
1985
8
0
191
1990
—
10
34
181
1908
26
98
148
1619
Physiotherapist
Z3226 [2001311560]
1.2e+00
2.0e+00
—
—
1.0e+50
2.1e+00
1.7e+00
cases:5.53%
controls:1.76%
cases:4.02%
controls:0.55%
—
—
—
—
cases:2.51%
controls:0.00%
cases:5.24%
controls:0.67%
cases:7.47%
controls:1.46%
11
35
188
1955
8
11
191
1979
—
—
5
0
194
1985
10
13
181
1929
13
25
161
1692
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
9.0e-01
2.0e+00
—
1.0e+50
—
2.0e+00
1.8e+00
cases:8.54%
controls:3.67%
cases:4.52%
controls:0.65%
—
—
cases:10.05%
controls:0.00%
—
—
cases:6.81%
controls:0.98%
cases:15.52%
controls:2.85%
17
73
182
1917
9
13
190
1977
—
20
0
179
1990
—
13
19
178
1923
27
49
147
1668
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.8e-01
6.8e-01
1.9e+00
—
2.5e+00
6.4e-01
4.7e-01
cases:25.13%
controls:20.25%
cases:21.61%
controls:12.26%
cases:14.07%
controls:2.41%
—
—
cases:16.58%
controls:1.56%
cases:20.94%
controls:12.20%
cases:39.08%
controls:28.54%
50
403
149
1587
43
244
156
1746
28
48
171
1942
—
33
31
166
1954
40
237
151
1705
68
490
106
1227
Bacteria identified in Urine by Culture
630-4 [3026008]
6.1e-01
1.2e+00
2.5e+00
—
—
2.1e+00
1.2e+00
cases:6.53%
controls:3.67%
cases:5.03%
controls:1.56%
cases:4.02%
controls:0.35%
—
—
—
—
cases:10.47%
controls:1.44%
cases:13.79%
controls:4.78%
13
73
186
1917
10
31
189
1959
8
7
191
1983
—
—
20
28
171
1914
24
82
150
1635
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1.5e-01
9.8e-01
3.1e+00
—
2.5e+00
6.2e-01
7.5e-01
cases:6.53%
controls:5.68%
cases:6.03%
controls:2.36%
cases:5.53%
controls:0.25%
—
—
cases:3.52%
controls:0.30%
cases:3.66%
controls:2.01%
cases:14.37%
controls:7.34%
13
113
186
1877
12
47
187
1943
11
5
188
1985
—
7
6
192
1979
7
39
184
1903
25
126
149
1591
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-7.0e-02
1.2e-01
1.3e+00
2.7e+00
1.6e+00
2.3e-01
-9.5e-02
cases:19.10%
controls:20.20%
cases:16.08%
controls:14.52%
cases:9.05%
controls:2.66%
cases:3.52%
controls:0.25%
cases:11.56%
controls:2.62%
cases:18.32%
controls:15.19%
cases:27.59%
controls:29.53%
38
402
161
1588
32
289
167
1701
18
53
181
1937
7
5
192
1985
23
52
176
1933
35
295
156
1647
48
507
126
1210
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.5e-01
6.9e-01
1.8e+00
—
2.5e+00
1.2e+00
4.5e-01
cases:10.05%
controls:7.29%
cases:8.04%
controls:4.22%
cases:4.02%
controls:0.70%
—
—
cases:4.02%
controls:0.35%
cases:10.99%
controls:3.55%
cases:17.24%
controls:11.71%
20
145
179
1845
16
84
183
1906
8
14
191
1976
—
8
7
191
1978
21
69
170
1873
30
201
144
1516
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.3e-01
7.0e-01
1.8e+00
—
2.5e+00
1.2e+00
4.5e-01
cases:9.55%
controls:7.04%
cases:8.04%
controls:4.17%
cases:4.02%
controls:0.70%
—
—
cases:4.02%
controls:0.35%
cases:10.99%
controls:3.55%
cases:17.24%
controls:11.71%
19
140
180
1850
16
83
183
1907
8
14
191
1976
—
8
7
191
1978
21
69
170
1873
30
201
144
1516
More than one and less than three hours
ZXE10 [2001311401]
6.9e-02
1.9e+00
—
—
—
2.1e+00
1.4e+00
cases:5.53%
controls:5.18%
cases:6.53%
controls:1.06%
—
—
—
—
—
—
cases:5.76%
controls:0.77%
cases:13.22%
controls:3.67%
11
103
188
1887
13
21
186
1969
—
—
—
11
15
180
1927
23
63
151
1654
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.8e-01
7.1e-01
1.8e+00
—
2.2e+00
1.2e+00
4.5e-01
cases:10.05%
controls:7.09%
cases:8.04%
controls:4.12%
cases:4.02%
controls:0.70%
—
—
cases:3.52%
controls:0.40%
cases:10.99%
controls:3.55%
cases:16.67%
controls:11.30%
20
141
179
1849
16
82
183
1908
8
14
191
1976
—
7
8
192
1977
21
69
170
1873
29
194
145
1523
Laboratory Visit
OMOP4822461 [32036]
-1.7e-02
1.8e-01
1.0e+00
3.0e+00
1.1e+00
2.3e-01
1.6e-01
cases:29.15%
controls:29.50%
cases:30.15%
controls:26.43%
cases:18.59%
controls:7.54%
cases:8.54%
controls:0.45%
cases:20.10%
controls:7.51%
cases:32.46%
controls:27.55%
cases:47.70%
controls:43.74%
58
587
141
1403
60
526
139
1464
37
150
162
1840
17
9
182
1981
40
149
159
1836
62
535
129
1407
83
751
91
966
Bacteria identified in Blood by Culture
600-7 [3023368]
5.5e-01
1.9e+00
—
—
—
1.8e+00
1.4e+00
cases:4.02%
controls:2.36%
cases:5.03%
controls:0.75%
—
—
—
—
—
—
cases:3.66%
controls:0.62%
cases:11.49%
controls:3.20%
8
47
191
1943
10
15
189
1975
—
—
—
7
12
184
1930
20
55
154
1662
duloxetine; oral
N06AX21 [21604749]
1.4e+00
1.3e+00
—
—
—
2.2e+00
1.5e+00
cases:5.53%
controls:1.46%
cases:3.02%
controls:0.85%
—
—
—
—
—
—
cases:6.28%
controls:0.77%
cases:7.47%
controls:1.75%
11
29
188
1961
6
17
193
1973
—
—
—
12
15
179
1927
13
30
161
1687
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
1.3e+00
—
—
—
—
2.0e+00
1.7e+00
cases:6.03%
controls:1.71%
—
—
—
—
—
—
—
—
cases:4.71%
controls:0.67%
cases:6.90%
controls:1.34%
12
34
187
1956
—
—
—
—
9
13
182
1929
12
23
162
1694
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
—
—
—
—
—
2.9e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:4.71%
controls:0.26%
cases:4.60%
controls:0.64%
—
—
—
—
—
9
5
182
1937
8
11
166
1706
amitriptyline; oral, parenteral
N06AA09 [21604696]
8.2e-01
1.8e+00
-1.0e+50
—
—
1.6e+00
1.5e+00
cases:7.54%
controls:3.47%
cases:8.54%
controls:1.46%
cases:0.00%
controls:0.30%
—
—
—
—
cases:7.33%
controls:1.60%
cases:12.64%
controls:3.09%
15
69
184
1921
17
29
182
1961
0
6
199
1984
—
—
14
31
177
1911
22
53
152
1664
Supplier / Service Provider
OMOP5117446 [33004]
-8.6e-01
-2.7e-01
-1.0e+50
—
—
2.4e+00
3.4e+00
cases:12.56%
controls:25.43%
cases:5.53%
controls:7.14%
cases:0.00%
controls:0.65%
—
—
—
—
cases:4.19%
controls:0.41%
cases:14.94%
controls:0.58%
25
506
174
1484
11
142
188
1848
0
13
199
1977
—
—
8
8
183
1934
26
10
148
1707
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.7e+00
1.6e+00
-1.0e+50
—
—
8.5e-01
1.4e+00
cases:9.05%
controls:1.76%
cases:5.03%
controls:1.06%
cases:0.00%
controls:0.30%
—
—
—
—
cases:2.62%
controls:1.13%
cases:8.62%
controls:2.21%
18
35
181
1955
10
21
189
1969
0
6
199
1984
—
—
5
22
186
1920
15
38
159
1679
macrogol; oral
A06AD15 [21600575]
—
2.0e+00
—
—
—
2.7e+00
1.1e+00
—
—
cases:3.02%
controls:0.40%
—
—
—
—
—
—
cases:5.76%
controls:0.41%
cases:4.60%
controls:1.57%
—
6
8
193
1982
—
—
—
11
8
180
1934
8
27
166
1690
Home Visit
OMOP4822459 [581476]
1.5e-01
7.7e-01
1.5e+00
—
2.1e+00
1.6e+00
9.8e-01
cases:4.02%
controls:3.47%
cases:4.02%
controls:1.91%
cases:3.02%
controls:0.70%
—
—
cases:5.03%
controls:0.65%
cases:9.42%
controls:2.06%
cases:13.79%
controls:5.65%
8
69
191
1921
8
38
191
1952
6
14
193
1976
—
10
13
189
1972
18
40
173
1902
24
97
150
1620
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
6.2e-01
1.5e+00
—
—
—
1.7e+00
1.4e+00
cases:7.04%
controls:3.92%
cases:5.53%
controls:1.26%
—
—
—
—
—
—
cases:6.28%
controls:1.24%
cases:14.37%
controls:3.96%
14
78
185
1912
11
25
188
1965
—
—
—
12
24
179
1918
25
68
149
1649
Scheduled procedure
ZXD10 [2001311387]
-1.1e-01
1.5e+00
—
—
—
1.4e+00
1.7e+00
cases:5.03%
controls:5.58%
cases:5.53%
controls:1.26%
—
—
—
—
—
—
cases:5.76%
controls:1.49%
cases:17.82%
controls:3.96%
10
111
189
1879
11
25
188
1965
—
—
—
11
29
180
1913
31
68
143
1649
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
3.0e-01
2.9e-01
2.1e+00
—
2.5e+00
5.6e-01
4.5e-01
cases:26.13%
controls:20.70%
cases:20.60%
controls:16.28%
cases:15.08%
controls:2.21%
—
—
cases:17.59%
controls:1.76%
cases:24.08%
controls:15.29%
cases:41.38%
controls:31.04%
52
412
147
1578
41
324
158
1666
30
44
169
1946
—
35
35
164
1950
46
297
145
1645
72
533
102
1184
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
3.2e-01
2.3e-01
2.1e+00
—
2.4e+00
5.7e-01
4.5e-01
cases:26.13%
controls:20.40%
cases:19.60%
controls:16.18%
cases:15.08%
controls:2.21%
—
—
cases:17.59%
controls:1.81%
cases:24.08%
controls:15.24%
cases:41.38%
controls:30.98%
52
406
147
1584
39
322
160
1668
30
44
169
1946
—
35
36
164
1949
46
296
145
1646
72
532
102
1185
Limited function/disability NOS
A28 [2002000162]
—
—
2.5e+00
—
—
2.0e+00
1.0e+00
—
—
—
—
cases:3.02%
controls:0.25%
—
—
—
—
cases:4.71%
controls:0.67%
cases:5.17%
controls:1.92%
—
—
6
5
193
1985
—
—
9
13
182
1929
9
33
165
1684
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
—
—
1.0e+50
1.0e+50
—
2.6e+00
1.8e+00
—
—
—
—
cases:5.53%
controls:0.00%
cases:8.54%
controls:0.00%
—
—
cases:5.24%
controls:0.41%
cases:6.90%
controls:1.16%
—
—
11
0
188
1990
17
0
182
1990
—
10
8
181
1934
12
20
162
1697
Case Management Agency
251B00000X [38004193]
2.0e-01
2.1e-01
7.1e-01
2.9e+00
7.0e-01
2.9e-01
2.7e-01
cases:52.26%
controls:47.39%
cases:47.74%
controls:42.66%
cases:30.65%
controls:17.79%
cases:19.10%
controls:1.31%
cases:30.65%
controls:17.93%
cases:51.83%
controls:44.59%
cases:68.97%
controls:62.90%
104
943
95
1047
95
849
104
1141
61
354
138
1636
38
26
161
1964
61
356
138
1629
99
866
92
1076
120
1080
54
637
Urgent procedure
ZXD05 [2001311386]
6.4e-01
2.5e+00
—
1.0e+50
—
1.7e+00
8.2e-01
cases:7.04%
controls:3.82%
cases:10.55%
controls:1.01%
—
—
cases:4.02%
controls:0.00%
—
—
cases:4.19%
controls:0.77%
cases:6.90%
controls:3.15%
14
76
185
1914
21
20
178
1970
—
8
0
191
1990
—
8
15
183
1927
12
54
162
1663
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
6.3e-01
7.8e-01
—
—
2.2e+00
1.1e+00
7.4e-01
cases:12.56%
controls:7.14%
cases:7.04%
controls:3.37%
—
—
—
—
cases:5.03%
controls:0.55%
cases:8.38%
controls:3.09%
cases:19.54%
controls:10.43%
25
142
174
1848
14
67
185
1923
—
—
10
11
189
1974
16
60
175
1882
34
179
140
1538
Cystoscopy
UKC02 [2001306005]
—
—
—
—
—
2.4e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:5.24%
controls:0.51%
cases:6.90%
controls:1.40%
—
—
—
—
—
10
10
181
1932
12
24
162
1693
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
5.0e-01
8.5e-01
1.4e+00
—
2.8e+00
1.2e+00
4.4e-01
cases:9.05%
controls:5.68%
cases:6.53%
controls:2.91%
cases:2.51%
controls:0.60%
—
—
cases:4.02%
controls:0.25%
cases:8.38%
controls:2.78%
cases:13.22%
controls:8.91%
18
113
181
1877
13
58
186
1932
5
12
194
1978
—
8
5
191
1980
16
54
175
1888
23
153
151
1564
Uroflowmetry
44856007 [4261340]
—
—
—
—
—
2.2e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:5.76%
controls:0.67%
cases:8.62%
controls:1.63%
—
—
—
—
—
11
13
180
1929
15
28
159
1689
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
4.2e-01
—
—
—
—
2.3e+00
1.6e+00
cases:2.51%
controls:1.66%
—
—
—
—
—
—
—
—
cases:5.76%
controls:0.62%
cases:8.62%
controls:1.92%
5
33
194
1957
—
—
—
—
11
12
180
1930
15
33
159
1684
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
8.2e-01
8.3e-01
1.0e+50
—
2.8e+00
9.9e-01
9.9e-01
cases:10.55%
controls:4.92%
cases:5.03%
controls:2.26%
cases:2.51%
controls:0.00%
—
—
cases:4.02%
controls:0.25%
cases:5.24%
controls:2.01%
cases:16.09%
controls:6.64%
21
98
178
1892
10
45
189
1945
5
0
194
1990
—
8
5
191
1980
10
39
181
1903
28
114
146
1603
Essential (primary) hypertension
I10 [45591453]
4.2e-02
3.7e-01
2.1e+00
—
1.7e+00
5.2e-01
3.8e-01
cases:11.06%
controls:10.65%
cases:8.04%
controls:5.68%
cases:5.03%
controls:0.65%
—
—
cases:5.53%
controls:1.06%
cases:10.99%
controls:6.85%
cases:20.69%
controls:15.08%
22
212
177
1778
16
113
183
1877
10
13
189
1977
—
11
21
188
1964
21
133
170
1809
36
259
138
1458
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.7e-01
1.2e-01
1.8e+00
—
2.0e+00
4.8e-01
3.6e-01
cases:26.13%
controls:23.02%
cases:21.11%
controls:19.15%
cases:15.08%
controls:2.91%
—
—
cases:17.59%
controls:2.82%
cases:27.23%
controls:18.80%
cases:43.10%
controls:34.48%
52
458
147
1532
42
381
157
1609
30
58
169
1932
—
35
56
164
1929
52
365
139
1577
75
592
99
1125
quetiapine; oral
N05AH04 [21604544]
1.0e+00
1.2e+00
—
—
—
1.5e+00
1.2e+00
cases:7.54%
controls:2.86%
cases:6.03%
controls:1.91%
—
—
—
—
—
—
cases:7.85%
controls:1.85%
cases:9.77%
controls:3.03%
15
57
184
1933
12
38
187
1952
—
—
—
15
36
176
1906
17
52
157
1665
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.3e-01
3.2e-01
1.7e+00
—
2.0e+00
5.8e-01
5.5e-01
cases:19.60%
controls:16.23%
cases:17.09%
controls:12.96%
cases:10.55%
controls:2.11%
—
—
cases:12.56%
controls:1.86%
cases:21.47%
controls:13.23%
cases:35.63%
controls:24.17%
39
323
160
1667
34
258
165
1732
21
42
178
1948
—
25
37
174
1948
41
257
150
1685
62
415
112
1302
Normoblasts [#/volume] in Blood
715-3 [3021589]
4.6e-01
6.1e-01
1.6e+00
—
2.1e+00
6.1e-01
5.7e-01
cases:9.05%
controls:5.93%
cases:8.04%
controls:4.52%
cases:5.53%
controls:1.16%
—
—
cases:6.53%
controls:0.86%
cases:7.85%
controls:4.43%
cases:13.79%
controls:8.33%
18
118
181
1872
16
90
183
1900
11
23
188
1967
—
13
17
186
1968
15
86
176
1856
24
143
150
1574
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.8e-01
8.5e-01
2.2e+00
—
—
1.5e+00
8.2e-01
cases:6.03%
controls:4.62%
cases:5.03%
controls:2.21%
cases:3.02%
controls:0.35%
—
—
—
—
cases:8.38%
controls:1.96%
cases:13.22%
controls:6.29%
12
92
187
1898
10
44
189
1946
6
7
193
1983
—
—
16
38
175
1904
23
108
151
1609
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.6e-01
3.8e-01
1.8e+00
—
1.8e+00
6.8e-01
4.4e-01
cases:17.09%
controls:12.61%
cases:11.06%
controls:7.84%
cases:6.03%
controls:1.01%
—
—
cases:7.54%
controls:1.31%
cases:12.57%
controls:6.80%
cases:25.86%
controls:18.40%
34
251
165
1739
22
156
177
1834
12
20
187
1970
—
15
26
184
1959
24
132
167
1810
45
316
129
1401
Other and unspecified abdominal pain
R10.4 [45568113]
8.4e-01
1.6e+00
—
—
—
1.0e+00
1.2e+00
cases:11.56%
controls:5.33%
cases:6.53%
controls:1.36%
—
—
—
—
—
—
cases:4.19%
controls:1.54%
cases:12.64%
controls:4.31%
23
106
176
1884
13
27
186
1963
—
—
—
8
30
183
1912
22
74
152
1643
Respiratory and circulatory monitoring
WX700 [2001310817]
1.6e+00
1.7e+00
1.0e+50
—
—
—
2.0e+00
cases:5.53%
controls:1.16%
cases:3.02%
controls:0.55%
cases:4.52%
controls:0.00%
—
—
—
—
—
—
cases:10.34%
controls:1.57%
11
23
188
1967
6
11
193
1979
9
0
190
1990
—
—
—
18
27
156
1690
ibuprofen
R02AX02 [1588667]
5.2e-01
5.2e-01
1.1e+00
—
1.3e+00
6.5e-01
4.4e-01
cases:45.23%
controls:32.91%
cases:23.62%
controls:15.58%
cases:7.54%
controls:2.76%
—
—
cases:8.54%
controls:2.42%
cases:24.61%
controls:14.57%
cases:46.55%
controls:35.93%
90
655
109
1335
47
310
152
1680
15
55
184
1935
—
17
48
182
1937
47
283
144
1659
81
617
93
1100
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
5.2e-01
5.2e-01
1.1e+00
—
1.3e+00
6.5e-01
4.4e-01
cases:45.23%
controls:32.91%
cases:23.62%
controls:15.58%
cases:7.54%
controls:2.76%
—
—
cases:8.54%
controls:2.42%
cases:24.61%
controls:14.57%
cases:46.55%
controls:35.93%
90
655
109
1335
47
310
152
1680
15
55
184
1935
—
17
48
182
1937
47
283
144
1659
81
617
93
1100
Medical doctor
Z2221 [2001311556]
5.2e-01
1.1e+00
—
—
—
2.1e+00
1.4e+00
cases:6.03%
controls:3.67%
cases:4.52%
controls:1.56%
—
—
—
—
—
—
cases:5.24%
controls:0.67%
cases:10.34%
controls:2.80%
12
73
187
1917
9
31
190
1959
—
—
—
10
13
181
1929
18
48
156
1669
Urinary tract ultrasound examination
KH1AE [2001306329]
—
—
—
—
—
1.0e+50
3.5e+00
—
—
—
—
—
—
—
—
—
—
cases:2.62%
controls:0.00%
cases:8.62%
controls:0.29%
—
—
—
—
—
5
0
186
1942
15
5
159
1712
Exposure to other specified factors
X58 [45756411]
6.7e-01
—
—
1.0e+50
—
2.0e+00
1.4e+00
cases:2.51%
controls:1.31%
—
—
—
—
cases:4.02%
controls:0.00%
—
—
cases:4.19%
controls:0.57%
cases:6.90%
controls:1.86%
5
26
194
1964
—
—
8
0
191
1990
—
8
11
183
1931
12
32
162
1685
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
2.2e-01
5.5e-01
9.3e-01
-1.0e+50
1.7e+00
8.6e-01
8.6e-01
cases:30.15%
controls:25.68%
cases:21.11%
controls:13.32%
cases:6.03%
controls:2.46%
cases:0.00%
controls:0.25%
cases:13.07%
controls:2.77%
cases:28.80%
controls:14.62%
cases:51.15%
controls:30.63%
60
511
139
1479
42
265
157
1725
12
49
187
1941
0
5
199
1985
26
55
173
1930
55
284
136
1658
89
526
85
1191
CBC panel - Blood by Automated count
58410-2 [40761511]
0.0e+00
4.2e-01
1.5e+00
—
1.9e+00
4.5e-01
3.2e-01
cases:22.61%
controls:22.61%
cases:20.60%
controls:14.62%
cases:11.06%
controls:2.71%
—
—
cases:12.06%
controls:2.07%
cases:19.37%
controls:13.23%
cases:37.36%
controls:30.23%
45
450
154
1540
41
291
158
1699
22
54
177
1936
—
24
41
175
1944
37
257
154
1685
65
519
109
1198
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
8.9e-01
1.4e+00
—
—
—
2.0e+00
1.4e+00
cases:6.03%
controls:2.56%
cases:4.02%
controls:1.01%
—
—
—
—
—
—
cases:5.24%
controls:0.77%
cases:10.92%
controls:2.97%
12
51
187
1939
8
20
191
1970
—
—
—
10
15
181
1927
19
51
155
1666
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
6.7e-01
1.3e+00
—
—
—
2.1e+00
1.1e+00
cases:6.03%
controls:3.17%
cases:4.02%
controls:1.11%
—
—
—
—
—
—
cases:8.38%
controls:1.08%
cases:10.92%
controls:3.84%
12
63
187
1927
8
22
191
1968
—
—
—
16
21
175
1921
19
66
155
1651
Retention of urine
R33 [45587507]
—
—
—
—
—
3.2e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:5.76%
controls:0.26%
cases:4.60%
controls:1.05%
—
—
—
—
—
11
5
180
1937
8
18
166
1699
pantoprazole; oral, parenteral
A02BC02 [21600097]
5.1e-01
5.6e-01
4.9e-01
—
1.3e+00
9.7e-01
8.3e-01
cases:19.60%
controls:12.71%
cases:11.06%
controls:6.63%
cases:2.51%
controls:1.56%
—
—
cases:5.53%
controls:1.56%
cases:17.80%
controls:7.57%
cases:31.61%
controls:16.83%
39
253
160
1737
22
132
177
1858
5
31
194
1959
—
11
31
188
1954
34
147
157
1795
55
289
119
1428
Lumbago with sciatica
M54.4 [45553205]
—
1.8e+00
—
—
—
1.4e+00
1.3e+00
—
—
cases:4.02%
controls:0.70%
—
—
—
—
—
—
cases:3.14%
controls:0.77%
cases:6.90%
controls:2.04%
—
8
14
191
1976
—
—
—
6
15
185
1927
12
35
162
1682
Supine thorax X-ray examination
GD1QA [2001303648]
—
3.0e+00
—
—
—
—
7.7e-01
—
—
cases:5.03%
controls:0.25%
—
—
—
—
—
—
—
—
cases:3.45%
controls:1.63%
—
10
5
189
1985
—
—
—
—
6
28
168
1689
Car occupant [any] injured in unspecified traffic accident
V49.9 [45566025]
—
—
—
1.0e+50
—
—
2.9e+00
—
—
—
—
—
—
cases:6.53%
controls:0.00%
—
—
—
—
cases:6.90%
controls:0.41%
—
—
—
13
0
186
1990
—
—
12
7
162
1710
Osmolality of Urine
2695-5 [3026782]
4.6e-01
1.2e+00
—
—
—
1.6e+00
1.3e+00
cases:4.52%
controls:2.91%
cases:3.02%
controls:0.95%
—
—
—
—
—
—
cases:4.71%
controls:1.03%
cases:8.62%
controls:2.45%
9
58
190
1932
6
19
193
1971
—
—
—
9
20
182
1922
15
42
159
1675
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
1.0e+00
9.4e-01
—
—
—
1.7e+00
1.1e+00
cases:7.04%
controls:2.71%
cases:3.52%
controls:1.41%
—
—
—
—
—
—
cases:5.24%
controls:0.98%
cases:9.77%
controls:3.32%
14
54
185
1936
7
28
192
1962
—
—
—
10
19
181
1923
17
57
157
1660
Retained dental root
K08.3 [45543292]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.75%
controls:0.35%
—
—
—
—
—
—
10
6
164
1711
Extensive body CT
JN4BD [2001310899]
1.6e+00
2.8e+00
—
—
—
—
—
cases:3.02%
controls:0.60%
cases:4.02%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
6
12
193
1978
8
5
191
1985
—
—
—
—
—
Inpatient Visit
IP [9201]
8.2e-01
1.5e+00
—
1.0e+50
—
1.2e+00
1.3e+00
cases:8.54%
controls:3.97%
cases:6.53%
controls:1.56%
—
—
cases:5.03%
controls:0.00%
—
—
cases:5.24%
controls:1.60%
cases:15.52%
controls:4.72%
17
79
182
1911
13
31
186
1959
—
10
0
189
1990
—
10
31
181
1911
27
81
147
1636
Internal Medicine
11 [38004456]
4.3e-01
8.4e-01
5.8e-01
1.0e+50
8.0e-01
1.0e+00
9.3e-01
cases:27.64%
controls:19.85%
cases:15.08%
controls:7.14%
cases:3.02%
controls:1.71%
cases:3.52%
controls:0.00%
cases:3.52%
controls:1.61%
cases:18.32%
controls:7.42%
cases:35.63%
controls:18.00%
55
395
144
1595
30
142
169
1848
6
34
193
1956
7
0
192
1990
7
32
192
1953
35
144
156
1798
62
309
112
1408
trimethoprim; oral, parenteral
J01EA01 [21602931]
6.5e-01
8.5e-01
—
—
-1.0e+50
1.8e+00
9.3e-01
cases:8.04%
controls:4.37%
cases:4.02%
controls:1.76%
—
—
—
—
cases:0.00%
controls:0.35%
cases:8.90%
controls:1.60%
cases:12.64%
controls:5.42%
16
87
183
1903
8
35
191
1955
—
—
0
7
199
1978
17
31
174
1911
22
93
152
1624
Poisoning by systemic antibiotics
T36 [45756588]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.29%
—
—
—
—
—
—
7
5
167
1712
Abdominal X-ray examination without contrast
JN3AA [2001305553]
-1.0e+50
—
—
—
—
—
2.7e+00
cases:0.00%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.29%
0
7
199
1983
—
—
—
—
—
7
5
167
1712
Laceration/cut
S18 [2002000983]
4.4e-01
9.4e-01
—
—
—
1.7e+00
9.4e-01
cases:7.54%
controls:4.97%
cases:3.52%
controls:1.41%
—
—
—
—
—
—
cases:7.85%
controls:1.60%
cases:16.09%
controls:6.99%
15
99
184
1891
7
28
192
1962
—
—
—
15
31
176
1911
28
120
146
1597
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
2.5e-01
6.6e-01
—
—
—
1.6e+00
9.3e-01
cases:5.03%
controls:3.97%
cases:4.02%
controls:2.11%
—
—
—
—
—
—
cases:8.38%
controls:1.75%
cases:12.64%
controls:5.42%
10
79
189
1911
8
42
191
1948
—
—
—
16
34
175
1908
22
93
152
1624
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
6.9e-01
8.6e-01
—
—
2.5e+00
8.6e-01
7.7e-01
cases:10.05%
controls:5.33%
cases:6.53%
controls:2.86%
—
—
—
—
cases:6.03%
controls:0.50%
cases:7.33%
controls:3.24%
cases:14.37%
controls:7.22%
20
106
179
1884
13
57
186
1933
—
—
12
10
187
1975
14
63
177
1879
25
124
149
1593
Incontinence urine
U04 [2002001139]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.35%
—
—
—
—
—
—
7
6
167
1711
Intraoperative use of conventional X-ray imaging
ZXM10 [2001311446]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.35%
—
—
—
—
—
—
7
6
167
1711
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.17%
controls:0.47%
—
—
—
—
—
—
9
8
165
1709
Spinal stenosis
M48.0 [45557888]
1.5e+00
2.1e+00
—
1.0e+50
—
2.4e+00
9.3e-01
cases:4.02%
controls:0.95%
cases:2.51%
controls:0.30%
—
—
cases:3.02%
controls:0.00%
—
—
cases:5.24%
controls:0.51%
cases:4.60%
controls:1.86%
8
19
191
1971
5
6
194
1984
—
6
0
193
1990
—
10
10
181
1932
8
32
166
1685
Open wound of scalp
S01.0 [45592468]
2.3e+00
—
—
—
—
—
—
cases:4.52%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
9
9
190
1981
—
—
—
—
—
—
Other and unspecified convulsions
R56.8 [45602033]
2.3e+00
—
—
—
—
—
2.1e+00
cases:4.52%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
cases:2.87%
controls:0.35%
9
9
190
1981
—
—
—
—
—
5
6
169
1711
Hip X-ray examination
NF1AA [2001307894]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:2.62%
controls:0.26%
—
—
—
—
—
—
—
5
5
186
1937
—
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
—
—
—
—
—
2.3e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:2.62%
controls:0.26%
cases:4.60%
controls:1.34%
—
—
—
—
—
5
5
186
1937
8
23
166
1694
Foot and toes X-ray examination
NH3AA [2001308267]
—
—
—
1.0e+50
—
—
2.3e+00
—
—
—
—
—
—
cases:2.51%
controls:0.00%
—
—
—
—
cases:5.17%
controls:0.52%
—
—
—
5
0
194
1990
—
—
9
9
165
1708
pH of Arterial blood
2744-1 [3019977]
—
2.3e+00
—
—
—
—
1.1e+00
—
—
cases:3.02%
controls:0.30%
—
—
—
—
—
—
—
—
cases:4.02%
controls:1.34%
—
6
6
193
1984
—
—
—
—
7
23
167
1694
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.41%
—
—
—
—
—
—
7
7
167
1710
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
—
2.2e+00
—
—
—
1.5e+00
6.4e-01
—
—
cases:3.52%
controls:0.40%
—
—
—
—
—
—
cases:2.62%
controls:0.62%
cases:4.02%
controls:2.15%
—
7
8
192
1982
—
—
—
5
12
186
1930
7
37
167
1680
Intravenous general anesthesia
WX404 [2001310807]
5.7e-01
2.2e+00
—
—
—
—
1.5e+00
cases:3.52%
controls:2.01%
cases:3.02%
controls:0.35%
—
—
—
—
—
—
—
—
cases:2.87%
controls:0.64%
7
40
192
1950
6
7
193
1983
—
—
—
—
5
11
169
1706
FEV1
20150-9 [3024653]
7.7e-01
—
—
—
—
-1.0e+50
2.1e+00
cases:4.02%
controls:1.91%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
cases:4.60%
controls:0.58%
8
38
191
1952
—
—
—
—
0
8
191
1934
8
10
166
1707
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
7.7e-01
—
—
—
—
-1.0e+50
2.1e+00
cases:4.02%
controls:1.91%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
cases:4.60%
controls:0.58%
8
38
191
1952
—
—
—
—
0
8
191
1934
8
10
166
1707
FEV1/FVC
19926-5 [3011505]
7.7e-01
—
—
—
—
-1.0e+50
2.1e+00
cases:4.02%
controls:1.91%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
cases:4.60%
controls:0.58%
8
38
191
1952
—
—
—
—
0
8
191
1934
8
10
166
1707
12 lead EKG panel
34534-8 [3044889]
-4.8e-01
1.6e-01
1.6e+00
—
2.1e+00
1.9e-01
-3.0e-02
cases:7.54%
controls:11.66%
cases:7.04%
controls:6.08%
cases:3.52%
controls:0.75%
—
—
cases:3.52%
controls:0.45%
cases:6.28%
controls:5.25%
cases:14.37%
controls:14.74%
15
232
184
1758
14
121
185
1869
7
15
192
1975
—
7
9
192
1976
12
102
179
1840
25
253
149
1464
Urine symptom/complaint other
U07 [2002001142]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.52%
—
—
—
—
—
—
7
9
167
1708
Shoulder X-ray examination without contrast
NB1AA [2001307225]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.52%
—
—
—
—
—
—
7
9
167
1708
Extraction of root of tooth
EBA30 [2001301929]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.52%
—
—
—
—
—
—
7
9
167
1708
Nursing episode
950 [44777714]
—
2.3e+00
—
—
—
2.1e+00
—
—
—
cases:2.51%
controls:0.25%
—
—
—
—
—
—
cases:3.14%
controls:0.41%
—
—
—
5
5
194
1985
—
—
—
6
8
185
1934
—
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
—
—
—
—
—
2.1e+00
9.7e-01
—
—
—
—
—
—
—
—
—
—
cases:3.14%
controls:0.41%
cases:3.45%
controls:1.34%
—
—
—
—
—
6
8
185
1934
6
23
168
1694
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.2e+00
2.0e+00
—
—
—
—
1.1e+00
cases:3.52%
controls:1.11%
cases:3.02%
controls:0.40%
—
—
—
—
—
—
—
—
cases:2.87%
controls:0.93%
7
22
192
1968
6
8
193
1982
—
—
—
—
5
16
169
1701
Gas panel - Venous blood
24339-4 [3000991]
—
2.0e+00
—
—
—
—
—
—
—
cases:3.02%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
—
6
8
193
1982
—
—
—
—
—
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
-1.0e+50
-1.0e+50
—
—
—
—
2.0e+00
cases:0.00%
controls:0.55%
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
cases:6.32%
controls:0.87%
0
11
199
1979
0
6
199
1984
—
—
—
—
11
15
163
1702
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.45%
controls:0.47%
—
—
—
—
—
—
6
8
168
1709
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.45%
controls:0.47%
—
—
—
—
—
—
6
8
168
1709
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
2.2e-01
3.4e-01
2.0e+00
1.0e+50
—
7.8e-01
5.7e-01
cases:5.53%
controls:4.47%
cases:3.02%
controls:2.16%
cases:4.02%
controls:0.55%
cases:2.51%
controls:0.00%
—
—
cases:4.19%
controls:1.96%
cases:10.92%
controls:6.46%
11
89
188
1901
6
43
193
1947
8
11
191
1979
5
0
194
1990
—
8
38
183
1904
19
111
155
1606
clonazepam; oral, parenteral
N03AE01 [21604415]
1.6e+00
1.9e+00
—
—
—
1.8e+00
2.0e+00
cases:3.52%
controls:0.75%
cases:2.51%
controls:0.40%
—
—
—
—
—
—
cases:2.62%
controls:0.46%
cases:4.60%
controls:0.64%
7
15
192
1975
5
8
194
1982
—
—
—
5
9
186
1933
8
11
166
1706
lamotrigine; oral
N03AX09 [21604431]
1.9e+00
—
—
—
—
—
2.0e+00
cases:2.51%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
cases:4.60%
controls:0.64%
5
8
194
1982
—
—
—
—
—
8
11
166
1706
Unspecified haematuria
R31 [45553726]
-1.0e+50
—
—
—
—
—
2.0e+00
cases:0.00%
controls:0.80%
—
—
—
—
—
—
—
—
—
—
cases:4.60%
controls:0.64%
0
16
199
1974
—
—
—
—
—
8
11
166
1706
norfloxacin; oral
J01MA06 [21603013]
1.0e+00
—
—
—
—
—
2.0e+00
cases:2.51%
controls:0.90%
—
—
—
—
—
—
—
—
—
—
cases:5.75%
controls:0.82%
5
18
194
1972
—
—
—
—
—
10
14
164
1703
Handing over of treatment supplies
SPAT1262 [2001700363]
5.3e-01
6.3e-01
—
—
—
2.0e+00
7.4e-01
cases:3.52%
controls:2.11%
cases:2.51%
controls:1.36%
—
—
—
—
—
—
cases:8.38%
controls:1.24%
cases:7.47%
controls:3.73%
7
42
192
1948
5
27
194
1963
—
—
—
16
24
175
1918
13
64
161
1653
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
-1.0e+50
-1.0e+50
—
—
—
—
2.0e+00
cases:0.00%
controls:0.55%
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
cases:6.32%
controls:0.93%
0
11
199
1979
0
6
199
1984
—
—
—
—
11
16
163
1701
FEV1 --post bronchodilation
20155-8 [3023550]
7.7e-01
—
—
—
—
-1.0e+50
2.0e+00
cases:3.52%
controls:1.66%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:4.02%
controls:0.58%
7
33
192
1957
—
—
—
—
0
5
191
1937
7
10
167
1707
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
7.7e-01
—
—
—
—
-1.0e+50
2.0e+00
cases:3.52%
controls:1.66%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:4.02%
controls:0.58%
7
33
192
1957
—
—
—
—
0
5
191
1937
7
10
167
1707
FEV1/FVC --post bronchodilation
69970-2 [42868459]
7.7e-01
—
—
—
—
-1.0e+50
2.0e+00
cases:3.52%
controls:1.66%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:4.02%
controls:0.58%
7
33
192
1957
—
—
—
—
0
5
191
1937
7
10
167
1707
FEV1 percent change
69983-5 [42868472]
7.7e-01
—
—
—
—
-1.0e+50
2.0e+00
cases:3.52%
controls:1.66%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:4.02%
controls:0.58%
7
33
192
1957
—
—
—
—
0
5
191
1937
7
10
167
1707
FVC percent change Respiratory system
69982-7 [42868471]
7.7e-01
—
—
—
—
-1.0e+50
2.0e+00
cases:3.52%
controls:1.66%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:4.02%
controls:0.58%
7
33
192
1957
—
—
—
—
0
5
191
1937
7
10
167
1707
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
—
—
1.0e+50
—
—
—
1.9e+00
—
—
—
—
cases:3.52%
controls:0.00%
—
—
—
—
—
—
cases:5.75%
controls:0.87%
—
—
7
0
192
1990
—
—
—
10
15
164
1702
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
-1.0e+50
-1.0e+50
—
—
—
—
1.9e+00
cases:0.00%
controls:0.55%
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
cases:6.32%
controls:0.99%
0
11
199
1979
0
6
199
1984
—
—
—
—
11
17
163
1700
Blasts/Leukocytes in Blood
26446-5 [3025159]
-1.0e+50
-1.0e+50
—
—
—
—
1.9e+00
cases:0.00%
controls:0.45%
cases:0.00%
controls:0.35%
—
—
—
—
—
—
—
—
cases:6.32%
controls:0.99%
0
9
199
1981
0
7
199
1983
—
—
—
—
11
17
163
1700
Abdominal ultrasound examination
JN3AE [2001305555]
1.5e+00
—
—
—
—
—
1.9e+00
cases:4.02%
controls:0.90%
—
—
—
—
—
—
—
—
—
—
cases:5.17%
controls:0.82%
8
18
191
1972
—
—
—
—
—
9
14
165
1703
Pain general/multiple sites
A01 [2002000142]
—
-1.0e+50
—
—
—
—
1.9e+00
—
—
cases:0.00%
controls:0.40%
—
—
—
—
—
—
—
—
cases:5.17%
controls:0.82%
—
0
8
199
1982
—
—
—
—
9
14
165
1703
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
4.2e-01
1.9e+00
—
—
—
1.4e+00
6.8e-01
cases:2.51%
controls:1.66%
cases:3.52%
controls:0.55%
—
—
—
—
—
—
cases:3.14%
controls:0.82%
cases:4.60%
controls:2.39%
5
33
194
1957
7
11
192
1979
—
—
—
6
16
185
1926
8
41
166
1676
Treatment of a patient needing special arrangements
WYA30 [2001310874]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.64%
—
—
—
—
—
—
7
11
167
1706
Catheterisation of bladder
TKC20 [2001306020]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.64%
—
—
—
—
—
—
7
11
167
1706
Pelvis X-ray examination
NE1AA [2001307792]
—
—
1.0e+50
1.0e+50
—
—
1.9e+00
—
—
—
—
cases:3.02%
controls:0.00%
cases:2.51%
controls:0.00%
—
—
—
—
cases:4.02%
controls:0.64%
—
—
6
0
193
1990
5
0
194
1990
—
—
7
11
167
1706
enoxaparin; parenteral
B01AB05 [21600976]
9.5e-02
1.1e+00
—
—
—
1.9e+00
8.8e-01
cases:4.02%
controls:3.67%
cases:3.52%
controls:1.16%
—
—
—
—
—
—
cases:4.19%
controls:0.67%
cases:9.20%
controls:4.02%
8
73
191
1917
7
23
192
1967
—
—
—
8
13
183
1929
16
69
158
1648
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
3.1e-01
4.1e-01
1.5e+00
—
1.9e+00
5.2e-01
2.5e-01
cases:13.07%
controls:9.95%
cases:7.54%
controls:5.13%
cases:2.51%
controls:0.55%
—
—
cases:5.53%
controls:0.91%
cases:8.38%
controls:5.15%
cases:18.39%
controls:14.97%
26
198
173
1792
15
102
184
1888
5
11
194
1979
—
11
18
188
1967
16
100
175
1842
32
257
142
1460
More than three and less than five hours
ZXE20 [2001311408]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.60%
controls:0.76%
—
—
—
—
—
—
8
13
166
1704
Ultrasound measurement of residual urine
KC1EE [2001305918]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.17%
controls:0.87%
—
—
—
—
—
—
9
15
165
1702
Low back pain
M54.5 [45553207]
3.7e-01
1.8e+00
—
—
—
5.9e-01
6.2e-01
cases:5.53%
controls:3.87%
cases:9.05%
controls:1.61%
—
—
—
—
—
—
cases:3.66%
controls:2.06%
cases:11.49%
controls:6.52%
11
77
188
1913
18
32
181
1958
—
—
—
7
40
184
1902
20
112
154
1605
pivmecillinam; oral
J01CA08 [21602827]
2.4e-01
1.9e-01
—
—
—
1.8e+00
5.2e-01
cases:9.05%
controls:7.24%
cases:3.02%
controls:2.51%
—
—
—
—
—
—
cases:8.90%
controls:1.60%
cases:10.92%
controls:6.81%
18
144
181
1846
6
50
193
1940
—
—
—
17
31
174
1911
19
117
155
1600
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
—
1.8e+00
—
—
—
1.9e+00
1.3e+00
—
—
cases:3.52%
controls:0.60%
—
—
—
—
—
—
cases:2.62%
controls:0.41%
cases:2.87%
controls:0.82%
—
7
12
192
1978
—
—
—
5
8
186
1934
5
14
169
1703
Abdominal CT examination
JN3AD [2001305554]
—
2.0e+00
—
—
—
—
1.8e+00
—
—
cases:2.51%
controls:0.35%
—
—
—
—
—
—
—
—
cases:6.90%
controls:1.22%
—
5
7
194
1983
—
—
—
—
12
21
162
1696
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
4.0e-01
1.8e+00
—
—
—
—
7.7e-01
cases:4.52%
controls:3.07%
cases:4.02%
controls:0.70%
—
—
—
—
—
—
—
—
cases:8.05%
controls:3.90%
9
61
190
1929
8
14
191
1976
—
—
—
—
14
67
160
1650
Abdominal pain/cramps general
D01 [2002000300]
1.7e+00
—
—
—
—
-1.0e+50
1.2e+00
cases:4.02%
controls:0.75%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
cases:4.02%
controls:1.22%
8
15
191
1975
—
—
—
—
0
9
191
1933
7
21
167
1696
oxycodone and naloxone; oral
N02AA55 [21604265]
—
—
—
—
—
1.6e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:3.66%
controls:0.77%
cases:8.05%
controls:1.57%
—
—
—
—
—
7
15
184
1927
14
27
160
1690
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
3.5e-01
—
—
—
—
1.7e+00
9.9e-01
cases:3.52%
controls:2.51%
—
—
—
—
—
—
—
—
cases:5.24%
controls:1.03%
cases:8.05%
controls:3.15%
7
50
192
1940
—
—
—
—
10
20
181
1922
14
54
160
1663
Other specified counselling
Z71.8 [45581061]
5.7e-01
6.4e-01
—
—
—
1.7e+00
8.4e-01
cases:5.03%
controls:2.91%
cases:3.02%
controls:1.61%
—
—
—
—
—
—
cases:7.85%
controls:1.60%
cases:10.92%
controls:5.01%
10
58
189
1932
6
32
193
1958
—
—
—
15
31
176
1911
19
86
155
1631
sildenafil; oral
G04BE03 [21602648]
3.0e-01
—
—
—
—
1.7e+00
9.9e-01
cases:3.02%
controls:2.26%
—
—
—
—
—
—
—
—
cases:7.85%
controls:1.60%
cases:8.62%
controls:3.38%
6
45
193
1945
—
—
—
—
15
31
176
1911
15
58
159
1659
Infectious Disease
44 [38004484]
1.5e+00
—
—
—
—
—
1.7e+00
cases:4.02%
controls:0.95%
—
—
—
—
—
—
—
—
—
—
cases:6.90%
controls:1.40%
8
19
191
1971
—
—
—
—
—
12
24
162
1693
Bacteria [Presence] in Urine
87829-8 [36304419]
2.8e-01
4.9e-01
—
—
—
1.6e+00
8.2e-01
cases:4.52%
controls:3.47%
cases:3.02%
controls:1.86%
—
—
—
—
—
—
cases:7.33%
controls:1.54%
cases:9.77%
controls:4.54%
9
69
190
1921
6
37
193
1953
—
—
—
14
30
177
1912
17
78
157
1639
lactulose; oral
A06AD11 [21600571]
1.2e+00
1.7e+00
—
—
—
—
1.6e+00
cases:4.02%
controls:1.26%
cases:3.52%
controls:0.65%
—
—
—
—
—
—
—
—
cases:6.32%
controls:1.34%
8
25
191
1965
7
13
192
1977
—
—
—
—
11
23
163
1694
temazepam; oral
N05CD07 [21604642]
9.1e-01
8.3e-01
-1.0e+50
—
—
9.3e-01
1.6e+00
cases:6.03%
controls:2.51%
cases:3.52%
controls:1.56%
cases:0.00%
controls:0.35%
—
—
—
—
cases:4.19%
controls:1.70%
cases:9.77%
controls:2.15%
12
50
187
1940
7
31
192
1959
0
7
199
1983
—
—
8
33
183
1909
17
37
157
1680
Localized oedema
R60.0 [45597193]
1.2e+00
—
—
—
—
—
1.5e+00
cases:3.52%
controls:1.06%
—
—
—
—
—
—
—
—
—
—
cases:5.17%
controls:1.16%
7
21
192
1969
—
—
—
—
—
9
20
165
1697
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
5.6e-01
1.9e+00
—
1.0e+50
1.0e+50
—
1.5e+00
cases:2.51%
controls:1.46%
cases:2.51%
controls:0.40%
—
—
cases:2.51%
controls:0.00%
cases:3.52%
controls:0.00%
—
—
cases:5.17%
controls:1.16%
5
29
194
1961
5
8
194
1982
—
5
0
194
1990
7
0
192
1985
—
9
20
165
1697
tamsulosin; oral
G04CA02 [21602669]
1.8e-01
1.0e+00
—
—
—
1.5e+00
4.7e-01
cases:3.52%
controls:2.96%
cases:4.02%
controls:1.46%
—
—
—
—
—
—
cases:6.28%
controls:1.44%
cases:5.75%
controls:3.67%
7
59
192
1931
8
29
191
1961
—
—
—
12
28
179
1914
10
63
164
1654
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.6e-01
2.8e-01
—
—
—
1.5e+00
7.8e-01
cases:5.03%
controls:3.57%
cases:2.51%
controls:1.91%
—
—
—
—
—
—
cases:6.81%
controls:1.60%
cases:9.77%
controls:4.72%
10
71
189
1919
5
38
194
1952
—
—
—
13
31
178
1911
17
81
157
1636
Depressive episode, unspecified
F32.9 [45571760]
1.1e+00
—
—
—
—
2.2e+00
1.5e+00
cases:3.52%
controls:1.16%
—
—
—
—
—
—
—
—
cases:2.62%
controls:0.31%
cases:5.75%
controls:1.34%
7
23
192
1967
—
—
—
—
5
6
186
1936
10
23
164
1694
fluoxetine; oral
N06AB03 [21604711]
1.5e+00
—
—
—
—
—
1.4e+00
cases:4.52%
controls:1.06%
—
—
—
—
—
—
—
—
—
—
cases:3.45%
controls:0.87%
9
21
190
1969
—
—
—
—
—
6
15
168
1702
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
1.5e+00
—
—
—
—
—
—
cases:4.52%
controls:1.06%
—
—
—
—
—
—
—
—
—
—
—
—
9
21
190
1969
—
—
—
—
—
—
Rotator cuff syndrome
M75.1 [45596678]
1.5e+00
5.2e-01
-1.0e+50
—
—
—
6.7e-01
cases:7.54%
controls:1.81%
cases:2.51%
controls:1.51%
cases:0.00%
controls:0.35%
—
—
—
—
—
—
cases:7.47%
controls:3.96%
15
36
184
1954
5
30
194
1960
0
7
199
1983
—
—
—
13
68
161
1649
Urinary tract infection, site not specified
N39.0 [45548665]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.32%
controls:1.51%
—
—
—
—
—
—
11
26
163
1691
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
8.4e-01
1.5e+00
—
—
-1.0e+50
—
1.4e-01
cases:10.05%
controls:4.62%
cases:6.03%
controls:1.46%
—
—
—
—
cases:0.00%
controls:0.35%
—
—
cases:4.60%
controls:4.02%
20
92
179
1898
12
29
187
1961
—
—
0
7
199
1978
—
8
69
166
1648
No procedures
SPAT1301 [2001700402]
0.0e+00
1.3e+00
-1.0e+50
—
—
1.5e+00
5.6e-01
cases:5.03%
controls:5.03%
cases:5.03%
controls:1.46%
cases:0.00%
controls:0.35%
—
—
—
—
cases:5.76%
controls:1.39%
cases:8.05%
controls:4.78%
10
100
189
1890
10
29
189
1961
0
7
199
1983
—
—
11
27
180
1915
14
82
160
1635
Acute tubulo-interstitial nephritis
N10 [45543856]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.90%
controls:1.75%
—
—
—
—
—
—
12
30
162
1687
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
2.8e-01
—
—
—
—
—
1.4e+00
cases:2.51%
controls:1.91%
—
—
—
—
—
—
—
—
—
—
cases:9.20%
controls:2.39%
5
38
194
1952
—
—
—
—
—
16
41
158
1676
Other specified special examinations
Z01.8 [45581003]
6.9e-01
—
—
—
—
1.7e+00
1.4e+00
cases:4.02%
controls:2.06%
—
—
—
—
—
—
—
—
cases:3.66%
controls:0.67%
cases:9.77%
controls:2.56%
8
41
191
1949
—
—
—
—
7
13
184
1929
17
44
157
1673
Sedation and analgesia
WX002 [2001310758]
6.0e-01
—
—
—
—
—
1.4e+00
cases:3.52%
controls:1.96%
—
—
—
—
—
—
—
—
—
—
cases:7.47%
controls:1.92%
7
39
192
1951
—
—
—
—
—
13
33
161
1684
melatonin; oral
N05CH01 [21604659]
9.0e-01
—
—
—
—
1.4e+00
9.9e-01
cases:3.52%
controls:1.46%
—
—
—
—
—
—
—
—
cases:5.24%
controls:1.34%
cases:8.05%
controls:3.15%
7
29
192
1961
—
—
—
—
10
26
181
1916
14
54
160
1663
Fever
A03 [2002000144]
1.4e+00
—
—
—
—
—
—
cases:5.03%
controls:1.31%
—
—
—
—
—
—
—
—
—
—
—
—
10
26
189
1964
—
—
—
—
—
—
Leukocytes [#/volume] in Urine
30405-5 [3018095]
2.2e-01
4.7e-01
—
—
—
1.3e+00
7.2e-01
cases:5.53%
controls:4.47%
cases:4.52%
controls:2.86%
—
—
—
—
—
—
cases:8.38%
controls:2.32%
cases:13.22%
controls:6.87%
11
89
188
1901
9
57
190
1933
—
—
—
16
45
175
1897
23
118
151
1599
pH of Urine
2756-5 [3015736]
4.9e-01
7.6e-01
—
—
—
1.3e+00
3.1e-01
cases:8.54%
controls:5.43%
cases:6.53%
controls:3.17%
—
—
—
—
—
—
cases:8.38%
controls:2.37%
cases:12.07%
controls:9.14%
17
108
182
1882
13
63
186
1927
—
—
—
16
46
175
1896
21
157
153
1560
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.8e-01
8.6e-02
1.1e+00
—
1.3e+00
3.2e-01
1.7e-01
cases:25.13%
controls:21.86%
cases:17.59%
controls:16.38%
cases:6.53%
controls:2.36%
—
—
cases:10.05%
controls:2.97%
cases:21.47%
controls:16.58%
cases:36.21%
controls:32.38%
50
435
149
1555
35
326
164
1664
13
47
186
1943
—
20
59
179
1926
41
322
150
1620
63
556
111
1161
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
4.2e-01
8.3e-01
1.6e+00
—
—
1.3e+00
5.7e-01
cases:5.53%
controls:3.72%
cases:5.03%
controls:2.26%
cases:3.02%
controls:0.60%
—
—
—
—
cases:7.33%
controls:2.16%
cases:10.92%
controls:6.46%
11
74
188
1916
10
45
189
1945
6
12
193
1978
—
—
14
42
177
1900
19
111
155
1606
One hour or less
ZXE00 [2001311394]
3.8e-01
8.9e-01
—
—
—
1.3e+00
1.3e+00
cases:8.54%
controls:5.98%
cases:3.02%
controls:1.26%
—
—
—
—
—
—
cases:4.19%
controls:1.18%
cases:14.37%
controls:4.48%
17
119
182
1871
6
25
193
1965
—
—
—
8
23
183
1919
25
77
149
1640
zopiclone; oral
N05CF01 [21604654]
6.1e-01
9.2e-01
1.1e+00
—
—
1.3e+00
6.3e-01
cases:11.56%
controls:6.63%
cases:7.04%
controls:2.91%
cases:2.51%
controls:0.85%
—
—
—
—
cases:10.99%
controls:3.35%
cases:11.49%
controls:6.46%
23
132
176
1858
14
58
185
1932
5
17
194
1973
—
—
21
65
170
1877
20
111
154
1606
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
8.3e-01
—
—
—
—
—
1.3e+00
cases:6.03%
controls:2.71%
—
—
—
—
—
—
—
—
—
—
cases:8.62%
controls:2.62%
12
54
187
1936
—
—
—
—
—
15
45
159
1672
nitrofurantoin; oral
J01XE01 [21603058]
—
—
—
—
—
1.6e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:2.62%
controls:0.57%
cases:6.90%
controls:2.10%
—
—
—
—
—
5
11
186
1931
12
36
162
1681
calcium (different salts in combination); oral
A12AA20 [21600872]
6.8e-01
7.2e-01
—
—
—
1.2e+00
7.8e-01
cases:9.55%
controls:5.08%
cases:9.05%
controls:4.62%
—
—
—
—
—
—
cases:13.61%
controls:4.38%
cases:14.37%
controls:7.16%
19
101
180
1889
18
92
181
1898
—
—
—
26
85
165
1857
25
123
149
1594
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
3.9e-01
9.3e-01
—
—
—
1.2e+00
1.2e+00
cases:7.54%
controls:5.23%
cases:3.02%
controls:1.21%
—
—
—
—
—
—
cases:5.76%
controls:1.85%
cases:17.82%
controls:5.94%
15
104
184
1886
6
24
193
1966
—
—
—
11
36
180
1906
31
102
143
1615
Left side
ZXA05 [2001311347]
-2.0e-02
—
—
—
—
—
1.2e+00
cases:2.51%
controls:2.56%
—
—
—
—
—
—
—
—
—
—
cases:8.05%
controls:2.62%
5
51
194
1939
—
—
—
—
—
14
45
160
1672
Treatment plan or consultation
WZC00 [2001310885]
1.2e+00
8.5e-01
2.3e+00
—
—
9.9e-01
8.2e-01
cases:10.55%
controls:3.57%
cases:3.02%
controls:1.31%
cases:2.51%
controls:0.25%
—
—
—
—
cases:3.14%
controls:1.18%
cases:9.20%
controls:4.25%
21
71
178
1919
6
26
193
1964
5
5
194
1985
—
—
6
23
185
1919
16
73
158
1644
Pharmacy visit
OMOP4822462 [581458]
5.6e-02
6.6e-01
6.3e-01
9.8e-01
5.3e-01
7.4e-01
9.7e-01
cases:92.46%
controls:92.06%
cases:87.44%
controls:78.29%
cases:52.76%
controls:37.29%
cases:7.04%
controls:2.76%
cases:51.26%
controls:38.29%
cases:89.01%
controls:79.51%
cases:97.70%
controls:94.18%
184
1832
15
158
174
1558
25
432
105
742
94
1248
14
55
185
1935
102
760
97
1225
170
1544
21
398
170
1617
4
100
clindamycin; oral, parenteral
J01FF01 [21602985]
1.1e+00
—
—
—
—
—
8.7e-01
cases:7.04%
controls:2.46%
—
—
—
—
—
—
—
—
—
—
cases:7.47%
controls:3.26%
14
49
185
1941
—
—
—
—
—
13
56
161
1661
Pain in joint
M25.5 [45586941]
1.1e+00
—
—
—
-1.0e+50
—
2.6e-01
cases:9.05%
controls:3.22%
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
cases:5.75%
controls:4.48%
18
64
181
1926
—
—
—
0
6
199
1979
—
10
77
164
1640
Complicated extraction of tooth
EBA05 [2001301924]
—
—
—
—
—
-1.0e+50
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
cases:8.62%
controls:3.15%
—
—
—
—
—
0
12
191
1930
15
54
159
1663
Telephone prescription or other care instructions
WZB00 [2001310884]
1.0e+00
—
—
—
-1.0e+50
8.5e-01
8.5e-01
cases:8.54%
controls:3.22%
—
—
—
—
—
—
cases:0.00%
controls:0.30%
cases:2.62%
controls:1.13%
cases:8.05%
controls:3.61%
17
64
182
1926
—
—
—
0
6
199
1979
5
22
186
1920
14
62
160
1655
Telehealth
OMOP5556618 [722455]
2.5e-01
6.8e-01
6.4e-01
—
1.2e+00
1.0e+00
5.7e-01
cases:21.61%
controls:17.69%
cases:12.56%
controls:6.78%
cases:3.02%
controls:1.61%
—
—
cases:3.52%
controls:1.06%
cases:16.75%
controls:6.69%
cases:27.01%
controls:17.24%
43
352
156
1638
25
135
174
1855
6
32
193
1958
—
7
21
192
1964
32
130
159
1812
47
296
127
1421
Hand Surgery
40 [38004480]
7.8e-01
-1.0e+50
—
—
—
1.6e+00
1.0e+00
cases:5.53%
controls:2.61%
cases:0.00%
controls:0.75%
—
—
—
—
—
—
cases:4.19%
controls:0.88%
cases:8.62%
controls:3.26%
11
52
188
1938
0
15
199
1975
—
—
—
8
17
183
1925
15
56
159
1661
Low back symptom/complaint
L03 [2002000628]
5.3e-01
1.1e+00
—
—
—
1.0e+00
1.0e+00
cases:4.52%
controls:2.71%
cases:3.02%
controls:1.06%
—
—
—
—
—
—
cases:4.19%
controls:1.54%
cases:10.92%
controls:4.25%
9
54
190
1936
6
21
193
1969
—
—
—
8
30
183
1912
19
73
155
1644
omeprazole; oral, parenteral
A02BC01 [21600096]
9.7e-01
1.0e+00
—
—
—
1.4e+00
1.0e+00
cases:8.04%
controls:3.22%
cases:3.52%
controls:1.31%
—
—
—
—
—
—
cases:5.24%
controls:1.39%
cases:9.20%
controls:3.55%
16
64
183
1926
7
26
192
1964
—
—
—
10
27
181
1915
16
61
158
1656
Sampling
SPAT1263 [2001700364]
5.9e-01
7.9e-01
—
—
—
8.6e-01
1.0e+00
cases:9.55%
controls:5.53%
cases:4.52%
controls:2.11%
—
—
—
—
—
—
cases:5.76%
controls:2.52%
cases:16.67%
controls:6.87%
19
110
180
1880
9
42
190
1948
—
—
—
11
49
180
1893
29
118
145
1599
tizanidine; oral
M03BX02 [21604116]
4.9e-01
8.9e-01
—
—
—
8.3e-01
6.3e-01
cases:20.10%
controls:13.37%
cases:10.55%
controls:4.62%
—
—
—
—
—
—
cases:9.42%
controls:4.33%
cases:21.84%
controls:12.99%
40
266
159
1724
21
92
178
1898
—
—
—
18
84
173
1858
38
223
136
1494
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
4.0e-01
—
—
—
—
—
8.9e-01
cases:8.04%
controls:5.53%
—
—
—
—
—
—
—
—
—
—
cases:12.07%
controls:5.36%
16
110
183
1880
—
—
—
—
—
21
92
153
1625
fluconazole; oral, parenteral
J02AC01 [21603080]
8.3e-01
6.4e-01
—
—
—
3.8e-01
4.5e-01
cases:12.06%
controls:5.63%
cases:3.02%
controls:1.61%
—
—
—
—
—
—
cases:2.62%
controls:1.80%
cases:7.47%
controls:4.89%
24
112
175
1878
6
32
193
1958
—
—
—
5
35
186
1907
13
84
161
1633
codeine and paracetamol
N02AJ06 [1123647]
4.9e-01
7.6e-01
8.3e-01
—
8.5e-01
8.1e-01
7.5e-01
cases:16.58%
controls:10.85%
cases:9.55%
controls:4.72%
cases:2.51%
controls:1.11%
—
—
cases:3.02%
controls:1.31%
cases:8.90%
controls:4.17%
cases:25.29%
controls:13.80%
33
216
166
1774
19
94
180
1896
5
22
194
1968
—
6
26
193
1959
17
81
174
1861
44
237
130
1480
amlodipine; oral
C08CA01 [21601747]
5.0e-01
4.3e-01
—
—
—
7.9e-01
7.4e-01
cases:8.54%
controls:5.38%
cases:7.04%
controls:4.67%
—
—
—
—
—
—
cases:10.47%
controls:5.05%
cases:17.24%
controls:9.03%
17
107
182
1883
14
93
185
1897
—
—
—
20
98
171
1844
30
155
144
1562
diclofenac; ointment
M02AA15 [21604051]
—
-1.0e+50
—
—
—
—
4.8e-01
—
—
cases:0.00%
controls:0.40%
—
—
—
—
—
—
—
—
cases:3.45%
controls:2.15%
—
0
8
199
1982
—
—
—
—
6
37
168
1680
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
9.8e-01
—
—
—
—
—
—
cases:3.02%
controls:1.16%
—
—
—
—
—
—
—
—
—
—
—
—
6
23
193
1967
—
—
—
—
—
—
verapamil; oral, parenteral
C08DA01 [21601767]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
0
9
191
1933
—
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
—
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.87%
controls:0.00%
—
—
—
—
—
—
5
0
169
1717
Single live birth
Z37.0 [45571346]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
—
0
5
199
1985
—
—
—
—
—
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
7.1e-01
—
—
—
—
—
2.4e-01
cases:3.02%
controls:1.51%
—
—
—
—
—
—
—
—
—
—
cases:2.87%
controls:2.27%
6
30
193
1960
—
—
—
—
—
5
39
169
1678
Three-surface restoration
SFA30 [2001310360]
-1.8e-02
1.5e-01
—
—
—
3.0e-01
2.1e-01
cases:6.03%
controls:6.13%
cases:2.51%
controls:2.16%
—
—
—
—
—
—
cases:2.62%
controls:1.96%
cases:9.20%
controls:7.57%
12
122
187
1868
5
43
194
1947
—
—
—
5
38
186
1904
16
130
158
1587
haemophilus influenzae B and hepatitis B
J07CA08 [21601379]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
199
1984
—
—
—
—
—
—
Resting ECG, 12 leads
FP1B5 [2001303119]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
0
5
174
1712
Operation for phimosis
KGH10 [2001306288]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
199
1985
—
—
—
—
—
—
Extraction of tooth
EBA00 [2001301923]
4.2e-01
6.7e-01
—
—
—
—
4.4e-01
cases:6.53%
controls:4.37%
cases:3.02%
controls:1.56%
—
—
—
—
—
—
—
—
cases:8.62%
controls:5.71%
13
87
186
1903
6
31
193
1959
—
—
—
—
15
98
159
1619
Trisomy 18 risk [Likelihood] in Fetus
43994-3 [3047352]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.40%
cases:0.00%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
0
8
199
1982
0
7
199
1983
—
—
—
—
—
Reduction mammoplasty with transposition of areola
HAD30 [2001303943]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
199
1984
—
—
—
—
—
—
Low pressure glaucoma
H40.11 [2000502333]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
199
1985
—
—
—
—
—
—
Predominantly allergic asthma
J45.0 [45557624]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
—
—
—
—
—
0
10
199
1980
—
—
—
—
—
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
—
—
—
—
—
—
4.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.17%
controls:3.32%
—
—
—
—
—
—
9
57
165
1660
biperiden; oral, parenteral
N04AA02 [21604447]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
199
1984
—
—
—
—
—
—
naproxen and esomeprazole; oral
M01AE52 [40254096]
7.9e-01
-1.0e+50
—
—
—
—
—
cases:2.51%
controls:1.16%
cases:0.00%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
5
23
194
1967
0
7
199
1983
—
—
—
—
—
Planned health check-up monitoring, health check-up performed based on individual need
SPAT1317 [2001700418]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.34%
—
—
—
—
—
—
0
23
174
1694
Psychological sympt/compl other
P29 [2002000823]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
1.0e+00
cases:0.00%
controls:0.85%
cases:0.00%
controls:0.25%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:3.45%
controls:1.28%
0
17
199
1973
0
5
199
1985
—
—
—
0
5
191
1937
6
22
168
1695
Acute bronchitis
J20 [45581849]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
0
8
191
1934
—
Urticaria, unspecified
L50.9 [45562541]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
0
7
199
1983
—
—
—
—
—
0
6
174
1711
methylprednisolone, combinations
H02BX01 [21602747]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
199
1982
—
—
—
—
—
—
pseudoephedrine; oral
R01BA02 [21603210]
9.7e-01
—
—
—
—
-1.0e+50
7.8e-01
cases:4.02%
controls:1.56%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
cases:2.87%
controls:1.34%
8
31
191
1959
—
—
—
—
0
11
191
1931
5
23
169
1694
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.87%
controls:0.58%
—
—
—
—
—
—
5
10
169
1707
Cat dander IgE Ab [Units/volume] in Serum
6833-8 [3023430]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
0
5
174
1712
Periodontitis NOS
K05.32 [2000502730]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
0
16
174
1701
Acute pharyngitis
J02 [45557615]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
0
5
174
1712
Monocytes [#/volume] in Blood
26484-6 [3001604]
-4.8e-02
-3.8e-02
—
—
1.3e+00
1.5e-01
4.9e-01
cases:6.53%
controls:6.83%
cases:4.02%
controls:4.17%
—
—
—
—
cases:2.51%
controls:0.71%
cases:4.71%
controls:4.07%
cases:14.37%
controls:9.32%
13
136
186
1854
8
83
191
1907
—
—
5
14
194
1971
9
79
182
1863
25
160
149
1557
Otolaryngology
4 [38004449]
5.0e-01
8.6e-01
—
—
—
3.7e-01
5.1e-01
cases:13.57%
controls:8.69%
cases:7.04%
controls:3.12%
—
—
—
—
—
—
cases:4.19%
controls:2.94%
cases:13.79%
controls:8.74%
27
173
172
1817
14
62
185
1928
—
—
—
8
57
183
1885
24
150
150
1567
Chronic hypertension
205 [2001600203]
4.6e-01
-1.0e+50
—
—
—
—
—
cases:2.51%
controls:1.61%
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
5
32
194
1958
0
6
199
1984
—
—
—
—
—
Local photocoagulation of retina
CKC10 [2001301393]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
6
174
1711
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
—
—
—
—
—
—
7.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.87%
controls:1.40%
—
—
—
—
—
—
5
24
169
1693
norethisterone; oral
G03DC02 [21602553]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
—
0
5
199
1985
—
—
—
—
—
Hearing loss, unspecified
H91.9 [45547996]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
0
5
199
1985
—
—
—
—
—
0
5
174
1712
Vaccination
SPAT1325 [2001700426]
-1.5e-01
—
—
—
—
-1.0e+50
3.2e-01
cases:2.51%
controls:2.91%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.98%
cases:5.75%
controls:4.25%
5
58
194
1932
—
—
—
—
0
19
191
1923
10
73
164
1644
chlorhexidine
S02AA09 [21605155]
4.2e-02
—
—
—
—
—
6.6e-01
cases:2.51%
controls:2.41%
—
—
—
—
—
—
—
—
—
—
cases:3.45%
controls:1.81%
5
48
194
1942
—
—
—
—
—
6
31
168
1686
Pap smear
SPAT1193 [2001700294]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
cases:0.00%
controls:1.40%
—
—
—
—
—
0
6
191
1936
0
24
174
1693
Urticaria
L50 [45543371]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
6
174
1711
Base excess in Arterial blood by calculation
1925-7 [3003396]
—
2.1e+00
—
—
—
—
1.2e+00
—
—
cases:2.51%
controls:0.30%
—
—
—
—
—
—
—
—
cases:4.60%
controls:1.40%
—
5
6
194
1984
—
—
—
—
8
24
166
1693
rabeprazole; oral
A02BC04 [21600099]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.90%
cases:0.00%
controls:0.55%
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
0
18
199
1972
0
11
199
1979
—
—
—
0
7
191
1935
—
Percutaneous or transvaginal puncture and recovery of oocyte
LAA10 [2001306406]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
199
1984
—
—
—
—
—
—
Other and unspecified premature depolarization
I49.4 [45543180]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
0
5
174
1712
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
2.9e-01
6.7e-01
—
—
—
9.0e-01
1.3e-01
cases:4.52%
controls:3.42%
cases:3.02%
controls:1.56%
—
—
—
—
—
—
cases:2.62%
controls:1.08%
cases:4.60%
controls:4.08%
9
68
190
1922
6
31
193
1959
—
—
—
5
21
186
1921
8
70
166
1647
Atrioventricular block, second degree
I44.1 [45543177]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
0
5
174
1712
Arthritis, unspecified
M13.9 [45567463]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.40%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
0
8
199
1982
—
—
—
0
5
191
1937
—
Other shoulder lesions
M75.8 [45572543]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
6
174
1711
lisinopril; oral
C09AA03 [21601787]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
0
5
199
1985
—
—
—
—
Senile incipient cataract
H25.0 [45576699]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
199
1980
—
—
—
—
—
—
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
F00.10*G30.1 [2000501573]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
199
1982
—
—
—
—
—
—
Outcome of delivery
Z37 [45581024]
1.2e-01
—
—
—
—
—
—
cases:4.52%
controls:4.02%
—
—
—
—
—
—
—
—
—
—
—
—
9
80
190
1910
—
—
—
—
—
—
Hyperglycaemia, unspecified
R73.9 [45602038]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
199
1985
—
—
—
—
—
—
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
-5.0e-02
6.0e-01
—
—
—
1.4e+00
-4.7e-01
cases:3.02%
controls:3.17%
cases:3.52%
controls:1.96%
—
—
—
—
—
—
cases:5.24%
controls:1.39%
cases:3.45%
controls:5.42%
6
63
193
1927
7
39
192
1951
—
—
—
10
27
181
1915
6
93
168
1624
cefadroxil; oral
J01DB05 [21602874]
7.4e-01
—
—
—
—
-1.0e+50
—
cases:3.52%
controls:1.71%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
7
34
192
1956
—
—
—
—
0
7
191
1935
—
Extensive health check-up of expecting family
SPAT1197 [2001700298]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.40%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.81%
—
0
8
199
1982
—
—
—
—
0
31
174
1686
pneumococcus, purified polysaccharides antigen conjugated
J07AL02 [21601313]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.52%
0
12
199
1978
—
—
—
—
—
0
9
174
1708
bisoprolol; oral
C07AB07 [21601689]
1.5e-01
9.8e-02
1.7e-01
-1.0e+50
—
2.2e-01
1.7e-01
cases:11.56%
controls:10.15%
cases:10.05%
controls:9.20%
cases:3.02%
controls:2.56%
cases:0.00%
controls:0.30%
—
—
cases:12.04%
controls:9.94%
cases:16.67%
controls:14.39%
23
202
176
1788
20
183
179
1807
6
51
193
1939
0
6
199
1984
—
23
193
168
1749
29
247
145
1470
Proctoscopy
UJG02 [2001305126]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
6
174
1711
Rupture of aminiotic membrane for induction of labor
MAC01 [2001306869]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
6
174
1711
natamycin; local oral
A01AB10 [21600020]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
199
1984
—
—
—
—
—
—
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.65%
—
—
—
—
—
—
—
—
—
—
—
—
0
13
199
1977
—
—
—
—
—
—
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
5.6e-01
7.8e-01
—
—
—
9.4e-02
2.9e-01
cases:23.62%
controls:14.97%
cases:10.05%
controls:4.87%
—
—
—
—
—
—
cases:5.24%
controls:4.79%
cases:18.39%
controls:14.39%
47
298
152
1692
20
97
179
1893
—
—
—
10
93
181
1849
32
247
142
1470
Iron deficiency anaemia
D50 [45571628]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
0
5
174
1712
Preterm labour and delivery
O60 [45539187]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
6
174
1711
Corns and callosities
L84 [45533651]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
0
5
199
1985
—
—
—
—
—
0
5
174
1712
Nonorganic sleep disorders
F51 [45552491]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
0
7
174
1710
pH of Serum or Plasma
2753-2 [3018418]
3.7e-01
9.1e-01
—
—
—
9.9e-01
7.7e-01
cases:5.03%
controls:3.52%
cases:4.02%
controls:1.66%
—
—
—
—
—
—
cases:3.14%
controls:1.18%
cases:9.77%
controls:4.78%
10
70
189
1920
8
33
191
1957
—
—
—
6
23
185
1919
17
82
157
1635
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
6.7e-01
1.6e+00
—
—
—
1.4e+00
7.6e-01
cases:2.51%
controls:1.31%
cases:3.02%
controls:0.65%
—
—
—
—
—
—
cases:3.14%
controls:0.82%
cases:4.02%
controls:1.92%
5
26
194
1964
6
13
193
1977
—
—
—
6
16
185
1926
7
33
167
1684
betamethasone
S02BA07 [21605169]
4.6e-01
—
-1.0e+50
—
—
3.1e-01
5.7e-01
cases:7.04%
controls:4.57%
—
—
cases:0.00%
controls:0.25%
—
—
—
—
cases:3.14%
controls:2.32%
cases:9.77%
controls:5.77%
14
91
185
1899
—
0
5
199
1985
—
—
6
45
185
1897
17
99
157
1618
Dry eye syndrome
H04.10 [2000502254]
—
—
—
—
—
—
8.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.87%
controls:1.28%
—
—
—
—
—
—
5
22
169
1695
Insect bite/sting
S12 [2002000977]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.50%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.76%
0
10
199
1980
—
—
—
—
—
0
13
174
1704
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
8.5e-01
—
—
—
—
1.3e+00
4.9e-01
cases:4.02%
controls:1.76%
—
—
—
—
—
—
—
—
cases:2.62%
controls:0.72%
cases:4.60%
controls:2.85%
8
35
191
1955
—
—
—
—
5
14
186
1928
8
49
166
1668
Periodic check-up in occupational healthcare
SPAT1368 [2001700469]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
199
1985
—
—
—
—
—
—
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.36%
—
—
—
—
—
—
—
—
—
—
—
—
0
27
199
1963
—
—
—
—
—
—
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
-9.8e-02
6.1e-01
—
—
—
8.1e-01
4.3e-01
cases:3.02%
controls:3.32%
cases:3.02%
controls:1.66%
—
—
—
—
—
—
cases:4.19%
controls:1.91%
cases:6.90%
controls:4.60%
6
66
193
1924
6
33
193
1957
—
—
—
8
37
183
1905
12
79
162
1638
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
—
-1.0e+50
—
—
—
—
5.6e-01
—
—
cases:0.00%
controls:0.65%
—
—
—
—
—
—
—
—
cases:4.60%
controls:2.68%
—
0
13
199
1977
—
—
—
—
8
46
166
1671
Digoxin [Moles/volume] in Serum or Plasma
14698-5 [3027456]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
199
1984
—
—
—
—
—
—
Need for immunization against influenza
Z25.1 [45581017]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
cases:0.00%
controls:0.31%
cases:0.00%
controls:0.76%
—
0
6
199
1984
—
—
—
0
6
191
1936
0
13
174
1704

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
97
451
3.25
14.95
4.8
2.9
—
—
—
0
0
87
445
2.70
10.42
6.5
4.5
—
—
—
0
0
122
749
2.63
9.89
13.2
11.2
1.22
1.19
inr
0.30
105
620
98
556
2.50
9.19
4.8
3.1
15.80
179.40
e6/l
0.80
82
431
67
321
2.64
8.92
3.7
2.9
484.97
527.38
mosm/kgh2o
1.02
59
282
74
376
2.54
8.69
3.7
2.6
4.24
4.51
e6/l
0.08
66
344
93
532
2.40
8.37
3.7
2.4
—
—
—
0
0
86
477
2.41
8.28
4.3
3.0
0.23
0.37
e6/l
0.63
68
350
47
197
2.81
8.04
4.3
3.3
5.66
7.42
umol/l
0.65
39
175
148
1056
2.57
7.89
7.8
4.3
3813.14
46.72
e6/l
—
7
18
44
185
2.77
7.44
13.7
11.2
7.41
7.42
ph
0.63
26
110
102
630
2.27
7.44
5.8
3.8
107.06
83.78
e6/l
0.15
82
449
54
254
2.55
7.30
3.2
2.3
—
—
—
0
0
43
182
2.74
7.17
14.0
11.3
0.88
1.26
mmol/l
0.26
36
159
117
773
2.25
7.15
4.2
2.8
—
—
estimate
—
0
0
133
928
2.31
7.09
9.7
7.3
9.85
11.56
umol/l
1.78
125
884
90
557
2.12
6.24
3.9
2.5
57.32
70.93
u/l
0.56
81
522
29
107
3.00
6.17
18.5
10.3
0.65
0.67
%
0.08
29
107
46
221
2.41
5.85
12.3
7.9
104.33
104.38
mmol/l
0.02
46
221
125
902
2.04
5.46
5.7
3.6
0.00
0.00
estimate
-0.00
33
190
124
894
2.03
5.40
5.7
3.6
0.00
0.00
estimate
-0.00
29
192
28
111
2.77
5.23
18.8
10.2
1.74
1.42
%
0.55
28
111
125
914
1.99
5.11
5.8
3.7
0.00
0.00
estimate
-0.00
32
173
28
113
2.72
5.06
3.8
3.7
1.21
1.22
mmol/l
0.48
23
97
105
729
1.93
4.95
7.2
5.1
33.53
36.09
g/l
3.59
100
697
160
1288
2.24
4.92
12.2
8.7
85.89
80.52
u/l
0.71
154
1227
80
510
1.95
4.83
4.6
3.0
0.00
0.00
estimate
-0.00
28
155
50
271
2.13
4.71
4.1
2.9
1.99
1.85
e6/l
0.07
29
137
99
682
1.90
4.70
5.5
3.5
0.00
0.00
estimate
-0.00
23
164
111
795
1.90
4.66
11.4
7.6
1.20
1.21
mmol/l
1.42
98
694
31
140
2.44
4.47
15.9
9.7
—
—
—
0
0
102
721
1.85
4.38
5.1
3.3
6.45
6.16
ph
1.62
60
408
76
491
1.89
4.32
5.4
3.7
0.00
0.02
estimate
0.68
32
177
40
206
2.18
4.26
1.3
1.3
—
—
—
0
0
7
7
10.30
4.04
3.3
2.0
—
—
—
0
0
31
147
2.31
4.01
2.8
4.2
7.38
7.38
ph
0.01
23
86
22
90
2.62
3.87
1.8
1.3
—
—
—
0
0
30
143
2.29
3.83
2.8
4.0
1.55
1.72
mmol/l
0.09
24
125
75
500
1.80
3.76
4.3
4.0
7.41
7.40
ph
1.53
55
352
37
194
2.11
3.75
2.0
1.7
—
—
—
0
0
14
49
3.00
3.26
1.6
1.5
136.22
265.21
ug/g
—
9
25
8
15
5.51
3.22
1.0
1.1
—
—
—
0
0
185
1664
2.59
3.12
31.6
14.9
29.54
23.60
mg/l
1.35
171
1355
98
738
1.65
3.00
10.9
6.9
1.19
1.21
mmol/l
1.90
92
689
24
117
2.20
2.92
1.3
1.9
1.22
1.49
g/l
0.33
24
111
59
393
1.71
2.86
4.9
3.6
—
0.00
—
0
6
186
1690
2.54
2.83
34.5
17.5
139.24
139.72
mmol/l
1.61
186
1659
56
369
1.72
2.82
2.7
1.7
1.64
1.25
mg/l
0.39
43
295
50
320
1.75
2.78
4.4
3.9
58.08
280.84
ng/l
1.18
37
240
186
1695
2.49
2.71
34.3
17.6
3.98
3.97
mmol/l
0.03
186
1662
39
237
1.80
2.57
2.3
2.2
144.72
128.31
ug/g
0.13
31
192
77
563
1.60
2.56
9.2
6.4
—
—
—
0
0
19
89
2.25
2.54
1.8
4.1
24.29
24.15
mmol/l
0.07
19
89
142
1203
1.63
2.48
5.4
3.3
58.01
46.89
u/l
0.83
134
1154
25
133
2.01
2.44
4.2
3.4
—
—
—
0
0
70
505
1.60
2.44
1.6
1.5
—
—
—
0
0
46
301
1.69
2.35
1.6
1.8
—
—
—
0
0
21
108
2.06
2.25
1.3
1.3
—
—
—
0
0
39
247
1.72
2.23
1.8
1.6
1426.78
1192.95
nmol/l
0.74
32
190
8
24
3.43
2.20
1.6
1.3
—
—
—
0
0
119
983
1.52
2.19
14.2
11.0
4.70
4.06
e9/l
1.34
105
869
15
68
2.30
2.17
1.4
1.3
—
—
—
0
0
145
1259
1.56
2.05
4.1
4.4
15.16
14.76
pmol/l
1.04
131
1172
9
32
2.90
2.03
1.0
1.1
—
—
—
0
0
52
364
1.58
2.02
1.8
2.0
—
—
—
0
0
23
129
1.89
1.95
3.2
2.3
6.03
6.10
ph
0.13
15
89
98
794
1.46
1.88
11.1
6.5
0.70
0.69
%
0.07
92
752
100
815
1.46
1.86
10.9
6.4
26.10
27.88
%
0.74
95
784
98
796
1.46
1.85
11.0
6.5
8.48
8.64
%
0.23
93
759
25
147
1.80
1.84
1.4
2.7
9.53
10.52
g/l
0.59
25
137
98
797
1.45
1.83
11.1
6.4
3.14
2.88
%
0.31
93
759
19
102
1.95
1.83
6.2
9.1
—
—
—
0
0
13
60
2.25
1.82
3.5
2.0
—
—
—
0
0
5
13
3.92
1.72
1.0
1.2
—
—
—
0
0
24
144
1.76
1.67
3.5
4.3
0.89
0.60
%
—
9
44
80
637
1.43
1.63
3.7
3.4
27.63
134.96
ng/l
0.61
66
438
106
888
1.41
1.62
10.3
6.3
1.96
1.91
e9/l
0.06
95
793
35
235
1.59
1.61
1.7
1.7
—
—
—
0
0
23
138
1.75
1.60
2.4
3.6
70.96
74.83
e9/l
0.27
18
98
104
870
1.41
1.60
10.3
6.3
0.04
0.04
e9/l
0.22
89
756
32
214
1.59
1.50
1.8
1.6
—
—
—
0
0
9
37
2.50
1.50
1.0
1.1
—
—
—
0
0
103
867
1.39
1.49
10.3
6.3
0.61
0.57
e9/l
0.71
89
756
10
45
2.29
1.49
3.3
1.8
—
—
—
0
0
35
240
1.56
1.48
2.6
2.5
24.72
23.61
%
0.16
35
229
7
28
2.55
1.46
1.9
1.3
—
—
—
0
0
9
39
2.37
1.45
7.8
5.1
—
—
—
0
0
24
152
1.66
1.39
3.5
4.6
0.00
0.28
%
—
9
39
6
23
2.66
1.38
1.2
1.8
10.83
11.39
mmol/l
—
6
23
21
129
1.70
1.36
2.1
2.4
5.69
6.61
ug/l
0.18
21
120
105
898
1.36
1.33
10.6
6.7
0.20
0.19
e9/l
0.00
91
792
187
1776
1.88
1.31
35.2
19.3
73.39
77.28
umol/l
1.69
187
1754
6
25
2.44
1.25
2.3
2.1
—
—
—
0
0
9
45
2.05
1.25
1.0
1.2
—
—
—
0
0
52
401
1.40
1.23
5.8
3.7
1.02
1.02
kg/l
0.00
38
270
93
792
1.33
1.17
17.2
11.0
0.00
0.00
e9/l
0.12
79
644
84
705
1.33
1.17
2.2
2.0
97.23
94.83
pmol/l
0.19
45
370
22
144
1.59
1.14
1.2
1.2
—
—
—
0
0
13
73
1.84
1.14
2.8
1.8
—
—
—
0
0
53
417
1.37
1.11
1.4
1.4
0.79
1.36
u/ml
0.79
15
115
10
52
1.97
1.08
1.4
1.2
—
—
—
0
0
15
90
1.72
1.07
2.5
1.6
—
—
—
0
0
49
384
1.37
1.05
1.5
1.5
4.22
2.46
g/l
0.64
33
238
77
646
1.31
1.05
2.5
2.0
—
—
—
0
0
16
99
1.67
1.03
2.8
1.5
—
—
—
0
0
54
433
1.34
1.00
3.7
2.7
339.00
340.95
umol/l
0.05
49
381
16
100
1.65
1.00
2.8
1.5
—
—
—
0
0
23
158
1.52
0.99
1.3
1.6
—
—
—
0
0
23
158
1.52
0.99
3.6
4.1
1.06
0.76
%
—
8
51
9
50
1.84
0.98
8.2
3.5
3.96
3.91
mmol/l
—
9
50
155
1439
1.35
0.96
37.3
18.7
13.90
13.54
%
2.77
155
1427
5
103
0.47
0.92
1.6
1.1
—
—
—
0
0
18
119
1.56
0.92
2.2
3.3
67.38
66.84
g/l
0.13
18
114
28
204
1.43
0.91
1.3
1.2
—
—
—
0
0
6
29
2.10
0.90
2.7
2.2
—
—
—
0
0
163
1530
1.36
0.90
5.3
5.3
1.79
1.88
mu/l
0.47
154
1432
11
64
1.76
0.88
1.9
1.6
—
7.24
—
0
10
6
30
2.03
0.87
1.2
1.0
0.64
7.99
u/ml
—
6
25
15
97
1.59
0.84
1.5
2.9
—
—
—
0
0
14
89
1.62
0.83
2.0
3.1
1.48
1.28
%
0.25
14
89
21
148
1.47
0.82
3.8
4.1
0.17
0.10
%
—
6
40
56
466
1.28
0.79
2.1
1.7
19.65
21.03
nmol/l
0.34
51
406
40
320
1.31
0.76
1.4
1.3
23.91
25.32
iu/ml
0.04
11
103
15
100
1.54
0.75
2.6
1.5
—
—
—
0
0
68
584
1.25
0.74
3.2
3.5
7.50
8.11
mmol/l
0.44
57
509
189
1832
1.63
0.74
42.5
22.7
90.83
90.67
fl
0.19
189
1821
7
39
1.82
0.73
1.3
3.5
53.64
60.45
%
—
7
39
189
1833
1.62
0.72
43.7
23.2
39.76
41.03
%
2.65
189
1822
189
1833
1.62
0.72
42.5
22.7
30.21
30.29
pg
0.26
189
1821
189
1834
1.61
0.70
42.9
22.9
132.75
137.57
g/l
3.92
189
1821
15
102
1.51
0.70
2.7
1.5
—
—
—
0
0
5
27
1.87
0.69
1.8
3.4
3.48
4.93
e9/l
—
5
27
7
44
1.61
0.66
1.9
1.3
74.71
262.66
e6/l
—
7
35
13
87
1.53
0.65
1.8
3.1
0.70
0.63
%
0.31
13
87
15
104
1.48
0.64
3.1
1.5
0.18
0.37
mg/l
—
10
48
180
1736
1.39
0.64
24.5
13.3
—
—
—
0
0
8
50
1.62
0.62
6.5
2.2
24.63
24.42
mmol/l
—
8
50
88
791
1.20
0.60
3.2
3.0
116.70
126.68
ug/l
0.17
83
758
8
53
1.53
0.59
1.3
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
23
180
1.31
0.52
1.7
1.8
—
—
—
0
0
11
76
1.47
0.49
7.7
4.4
36.97
36.96
°c
0.05
11
76
5
31
1.63
0.43
1.6
1.2
—
—
—
0
0
5
31
1.63
0.43
1.4
1.2
—
—
—
0
0
5
32
1.58
0.42
5.4
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.48
0.40
2.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
34
292
1.20
0.38
1.4
1.3
100.73
5.44
u/ml
0.46
14
109
64
701
0.87
0.37
3.4
3.1
—
—
—
0
0
9
71
1.28
0.36
1.2
1.3
—
—
—
0
0
5
80
0.62
0.36
1.8
1.4
10.12
25.71
iu/l
—
5
68
25
210
1.22
0.35
1.4
1.3
—
—
—
0
0
29
336
0.84
0.33
2.6
2.7
0.66
0.77
ug/l
0.33
20
203
5
73
0.68
0.26
2.0
2.2
—
—
—
0
0
5
39
1.29
0.23
1.8
3.3
59.80
57.13
%
—
5
39
19
220
0.85
0.23
1.2
1.4
—
—
—
0
0
18
154
1.19
0.22
1.3
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
3.5
—
13.09
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
57
534
1.09
0.19
11.6
6.5
—
—
—
0
0
7
61
1.15
0.17
1.1
1.3
10.29
9.21
u/l
—
7
45
8
73
1.10
0.16
8.4
2.8
—
—
—
0
0
163
1603
1.09
0.15
4.9
4.9
5.86
5.91
mmol/l
0.25
144
1503
56
531
1.08
0.14
3.3
3.6
35.08
68.76
mg/l
1.59
36
351
6
58
1.04
0.08
7.3
2.8
25.43
24.77
mmol/l
—
6
53
167
1655
1.06
0.06
4.5
5.0
4.56
4.59
mmol/l
0.13
151
1574
166
1673
0.95
0.05
5.3
5.6
2.74
2.70
mmol/l
0.20
149
1589
73
745
0.97
0.05
1.9
2.0
1.40
1.37
mmol/l
0.11
63
645
19
179
1.07
0.05
2.4
2.1
402.79
377.11
nmol/l
0.20
19
170
42
407
1.04
0.05
7.5
4.8
—
—
—
0
0
158
1571
1.03
0.02
6.1
6.1
38.04
39.28
mmol/mol
1.01
143
1503
158
1574
1.02
0.00
3.9
4.2
1.27
1.29
mmol/l
0.14
138
1475
54
544
0.99
0.00
3.9
4.3
5.55
12.01
mg/mmol
1.84
38
355
165
1645
1.02
0.00
4.6
4.9
1.37
1.43
mmol/l
0.88
147
1553
18
185
0.97
0.00
1.3
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
10.90
—
0
8
0
8
0.00
0.00
0.0
2.6
—
2374.38
—
0
8
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
6
64
0.94
0.00
2.3
1.2
0.96
0.91
g/l
—
6
64
7
77
0.91
0.00
1.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
56.25
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
0.42
—
0
5
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
5.0
—
11.29
—
0
7
0
7
0.00
-0.00
0.0
6.9
—
10.14
—
0
7
0
5
0.00
-0.00
0.0
9.0
—
26.00
—
0
5
0
7
0.00
-0.00
0.0
3.4
—
32.71
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
12.72
—
0
5
7
75
0.93
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
226.14
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_INJURY_NERVES_LUMBAR_SPINAL_CORD_ABDOMEN_LOWER_BACK_PELVIS_LEVEL – Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).